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ABSTRACT 
 
Development and Analytical Validation of a Gas Chromatography-Mass Spectrometry 
Method for the Assessment of Gastrointestinal Permeability and Intestinal Absorptive 
Capacity in Dogs. (December 2008) 
Heriberto Rodríguez Frausto, M.V.Z.; M.Sc., School of Veterinary Medicine and 
Zootechnia, Autonomous University of Zacatecas  
Co-Chairs of Advisory Committee: Dr. Jörg M. Steiner 
                                                                          Dr. Judith M. Ball 
  
 
Assessment of gastrointestinal permeability in vivo is considered a suitable 
method for the evaluation of gastrointestinal mucosal integrity. Probes commonly used 
include lactulose (L) and rhamnose (R) for the assessment of intestinal permeability, 
xylose (X) and 3-O-methylglucose (M) for the evaluation of intestinal absorptive 
capacity, and sucrose (S) for the assessment of gastric permeability. Traditionally, 
various methods have been used to quantify these markers in the urine after orogastric 
administration. However, urine collection is difficult and uncomfortable. A protocol 
based on the analysis of blood samples would be easier to perform. Thus, the aim of the 
first part of this project was to develop and validate a new gas chromatography-mass 
spectrometry (GC-MS) method for the quantification of five sugar probes in canine 
serum. The method was sensitive, accurate, precise, and reproducible for the 
simultaneous quantification of 5 sugar probes in serum. The aim of the second part of 
this project was to assess the kinetic profiles of these 5 sugar probes in serum after 
orogastric administration in dogs and to determine the optimal time point for sample 
collection. Dogs received a solution containing L (10 g/L), R (10 g/L), X (10 g/L), M (5 
g/L), and S (40 g/L) by orogastric intubation. Baseline blood samples were collected. 
Subsequent timed blood samples were taken for a 24 hours period. Significant changes in 
serum concentrations of all 5 sugars were detected after administration of the test dose 
(p<0.0001 for all 5 probes). Serum concentrations of L and R were significantly different 
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from baseline concentrations from 90 to 240 and from 60 to 300 min post dosing 
respectively, and those of X, M, and S were significantly different from 30 to 240 min 
after dosing (p<0.05 for all 5 probes). Variations of the mean sugar concentrations of all 
dogs at 90, 120, and 180 minutes were analyzed using a Kruskal-Wallis test. Based on 
the results, only two blood samples, one taken at baseline and a second sample obtained 
between 90 and 180 after dosing, appear to be sufficient for assessment of intestinal 
permeability and mucosal absorptive capacity using these sugar probes. 
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CHAPTER I 
 
INTRODUCTION 
 
The gastrointestinal (GI) mucosa is the largest interface between the body and 
the external environment.1 It is exposed to a variety of environmental factors, which may 
initiate and/or perpetuate a disease. One of the major challenges for clinicians and 
researchers in gastroenterology is inflammatory bowel disease (IBD). In humans, the 
etiology of this disease remains unknown and is often idiopathic.2 However, several 
diagnostic techniques are available for the characterization and localization of the 
mucosal lesions.3 Additionally, an important set of biological markers has been validated 
for the monitoring of IBD activity.4,5 However, these diagnostic techniques do not 
provide functional information about the intestinal epithelium. For several decades, 
gastrointestinal permeability and absorptive capacity tests have been considered to be a 
suitable tool for the assessment of mucosal barrier function in various gastrointestinal 
disease states. 
 
GASTROINTESTINAL TRACT PHYSIOLOGY  
The major functions of the GI tract include the digestion and absorption of 
nutrients, but it also serves as a protective barrier for digestive enzymes, pathogens, 
toxins, and other noxious luminal macromolecules.6 The GI mucosa is composed of a 
single layer of columnar epithelium.7 It is organized into villi and microvillus, which 
dramatically increases the absorptive surface area. The epithelium acts as a barrier lining 
the mucosal surface of the GI tract. Barrier function is achieved by several mechanisms,  
one of which is by the presence of well-organized intercellular junctions between the 
cells, known as tight junctions.7  
 
_________________ 
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The intercellular tight junctions separate the apical from the basolateral cell 
surface to maintain a cellular polarity, which is essential for the  regulation of passive 
diffusion of solutes and macromolecules through the cellular space.8 These intercellular 
connections are made up by a variety of proteins that regulate permeation through the 
paracellular pathway.9  
The structure of the intestinal epithelium involves a set of aqueous pores 
distributed along the crypt-villus axis, which exhibit a gradient in tight junction 
permeability.10 Small channels (radius <6 ) are relatively abundant at the tips of the 
villi, allowing the permeation of small molecules, such as mannitol, but excluding the 
passage of  larger molecules, such as lactulose.11,12 Intermediate sized channels (10-15 
) are located at the base of the villi and the largest channels (50-60 ), which occur in 
low abundance, are located in the crypts.13 Therefore, the paracellular pathway through 
the tight junctions at the level of the crypts is thought to be the route of permeation for 
disaccharides. The tight junctions at the level of the villi contain more strand structures 
and are, therefore, more selectively permeable to monosaccharides than those at the level 
of the crypts.14 However, the transcellular pathway in the area of the villi is thought to be 
the main route of permeation for monosaccharides, mainly because the cellular surface 
area is much larger than the surface area of the tight junctions.12 . 
 
INTESTINAL EPITHELIAL FUNCTION 
Transcellular absorption. The intestinal epithelium prevents the entry of 
pathogens, toxins, and undigested macromolecules across the mucosa, while 
simultaneously digesting and selectively absorbing nutrients.6 Such selective absorption 
is considered a complex mechanism, which depends on the physicochemical properties 
of the permeating substances (i.e., molecular size and molecular weight), as well as 
physiological factors, and intestinal epithelial characteristics, such as the polarized 
epithelial cellular structure, which ensures a selective distribution of protein transporters 
at the apical membrane.15 
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Macromolecules can cross the intestinal epithelium by transport through the cells 
(transcellular pathway) or between the cells (paracellular pathway). The transcellular 
transport can by permeation or by a carrier-mediated process. Carrier-mediated 
absorption can be active (ATP-dependent), or passive, driven by a electrochemical 
gradient.16 A molecule crossing from the apical to the basolateral membrane by passive 
diffusion must be lipophilic, which will permit rapid absorption due to its solubility in 
the lipid bilayer.17 In contrast, the transcellular absorption of hydrophilic compounds is 
carried out by substrate specific carriers or through active transport proteins.18 The 
transcellular transport of nutrients and other substances from the apical to basolateral 
membrane is ATP dependent and is complemented by a transepithelial electrochemical 
gradient generated by the basolaterally positioned Na+/K+-ATPase.16 The 
electrochemical gradient is essential for the passive permeation of some water-soluble 
substances through the paracellular pathway.19  
Paracellular permeation. Paracellular permeability of small molecules through 
the tight junctions is passive, driven by an electro-osmotic gradient or in response to the 
presence of luminal glucose.20 The paracellular mechanism dissipates any possibility of 
transepithelial gradient saturation that would stop the transcellular transport or cause 
back flux toward the intestinal lumen, thus maintaining an equilibrated internal and 
external environment.16 A component of this equilibrium is due to the small intestine 
becoming progressively less permeable towards the colon, which gradually affects the 
permeability of polar compounds along the intestinal tract.21 Thus, the low resistance of 
the small intestinal epithelial tissues at this level permits the passage of a significant 
proportion of solutes and water between epithelial cells (paracellular route).22 In general, 
up to 95% of the permeability of the small intestine is due to the paracellular route. 
Conversely, the paracellular transport of a molecule has a tendency to decrease from the 
small intestine to the colon due to decreases in the absorptive surface area, cell, and 
intercellular tight junctions.23 Thus, only approximately 5% of the mucosal permeability 
of the large intestine is attributable to the paracellular pathway. 
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The paracellular pathway is regulated by intercellular junctions, which contain 
specific transcellular proteins which make up a complex molecular net for the opening 
and closing of this pathway.20 Claudins and adhesion molecules are the major proteins 
that interact with intracellular proteins, such as zonula occludens (ZO)-1, which in turn 
interact with the actin cytoskeleton for regulation of the paracellular pathway.24  
 
FACTORS AFFECTING INTESTINAL EPITHELIAL PERMEABILITY 
Enteropathogens, allergens, toxins, and viruses affect the tight junctions, leading 
to an increased permeability, which is a common mechanism involved in the 
pathogenesis of inflammatory bowel disease.25 For example, in cell monolayers infected 
with Salmonella typhimurium (S. typhimurium), Zonulin-1 (ZO-1) expression was 
significantly decreased. Also, ZO-2, a zonula occludens protein located in the nucleus of 
epithelial cells and E-cadherin were downregulated in response to Salmonella 
infection.26 
Recent studies in colonic epithelial cells infected with Campylobacter jejuni, 
showed a decrease in transepithelial electrical resistance (TER) and a redistribution and 
de-phosphorylation of occludin that led to the opening of tight junctions.27 The same 
phenomenon was observed using an in-vivo permeability assay in rabbits perfused with 
zonula occludens toxin (Zot), a protein produced by Vibrio cholera, which induced 
modifications of cytoskeletal organization (monomer polymerization), leading to the 
opening of tight junctions due to the contraction of the perijunctional actin ring.27,28 The 
loss of TER as well as an altered distribution of several tight junction proteins have been 
observed in cells infected with rotavirus.29 Transmigration of polymorphonuclear cells 
by the epithelium are some other effects of cellular protein disruption caused by 
pathogens.30  
Stress factors have been associated with an increased intestinal permeability.31 
Studies in rats under provoked stress showed an increase in jejunal permeability for 
probes such as Cr-EDTA and horseradish peroxidase (HRP). The increased intestinal 
permeability of Cr-EDTA in stress situations has been associated with an augmented 
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concentration of colonic interferon gamma (IFN-).32 In another study, serum cortisol 
concentrations (as an indicator of stress) showed a positive correlation with an increase 
in the incidence of gastric ulcers and an increased intestinal permeability in response to 
sustained strenuous exercise.33  
 
METHODS FOR ASSESSING INTESTINAL PERMEABILITY  
In vitro methods. In vitro and in vivo methods have been developed to assess the 
integrity of the intestinal epithelium. The properties of the intestinal epithelium can be 
assessed in vitro by the measurement of transepithelial electrical resistance (TER), 
which reflects tight junction resistance,34 and by the measurement of permeability 
towards paracellular markers.35 The success of this model depends on how closely it 
mimics all the in vivo conditions. In vitro models such as Ussing chambers use excised 
epithelial tissue, membrane preparations, and cultured cells.36 Sections of the small 
intestine are prepared between two chambers containing buffer, and the measurement of 
transepithelial resistance and the passive or active transport of molecules across the 
epithelium is evaluated as indicators of intestinal barrier integrity.12  
In vivo methods. Anatomical and physiological characteristics of the mucosal 
epithelium play a significant role for in vivo methods. In vivo studies can be used to 
identify and localize lesions along the entire length of the digestive tract.37 Such methods 
have been developed in humans and several animal species. , these tests consist of the 
oral administration of a solution containing the test markers, which will be excreted in 
the urine and measured as a percentage recovery of the administered amount. 
 
MARKERS FOR THE EVALUATION OF PERMEABILITY IN VIVO  
Markers for gastrointestinal permeability testing have to meet several properties. 
The ideal marker would be 1) non-metabolizable, 2) not endogenously produced, 3) non-
toxic, 4) water soluble, 5) completely absorbed, 6) limited to the extracellular space, 7) 
excreted intact in the urine, and 8) easily measured.38,39 
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Polyethylene glycol. Polyethylene glycol (PEG) exists in many different 
polymer sizes. Studies evaluating the effect of PEG size on paracellular permeability 
have demonstrated that the bioavailability for PEG remained 100% for oligomers with a 
size around 600 Da.40 The most commonly used polymer is PEG 400, which has a 
molecular weight of 400 g/mol.38 PEG 400 is resistant to bacterial degradation, 
permeates the intestinal mucosa, and is excreted in urine in proportions ranging from 26 
to 72% of the administered dose.41’38 Smaller polymers have a molecular weight that is 
similar to some sugars (i.e., rhamnose with a molecular weight of 164 g/mol and 242 
g/mol for PEG). Some other polymers have a similar size to 51Cr-EDTA (359 g/mol). 
However, smaller polymers permeate the mucosa faster than rhamnose, while the 
permeation rate of the larger polymers (550 g/mol) is higher than those for 51Cr-EDTA 
or lactulose.41 Therefore, these differences in permeation rates and their tendency to be 
retained by tissues makes PEG less ideal for the evaluation of intestinal permeability.42  
51Cr-EDTA. Tests using radioactively labeled substances such as 51Cr-EDTA, 
were common when permeability testing was first evaluated some decades ago. Even 
though the radioactivity incorporated in the substance is lower than the radiation emitted 
during routine abdominal radiography, the application of radioactive tests has been 
decreasing.43’44 The radioactive marker 51Cr-EDTA is usually given at doses that are 
chemically stable. 51Cr-EDTA is not hydrolyzed by bacteria and the analysis of this 
radioisotope is considered simple.
 
Under physiologic conditions 51Cr-EDTA does not 
permeate any part of the intestinal mucosa. However, disease of any portion of the 
intestinal tract can cause an increased permeability of this marker. If combined with 
other markers and small intestinal lesions can thus be excluded an increase permeability 
towards 51Cr-EDTA would suggest a disorder of the large intestine.45  
Saccharides. Monosaccharides and disaccharides as well as synthetically 
modified sugars are the most common GI permeability markers used today.  Rhamnose, 
mannitol, xylose, and 3-O-methyl-D-glucose are monosaccharides with a molecular size 
of 0.5-0.6 nm.46 Lactulose, sucrose, and sucralose are the most commonly used 
disaccharides and have a molecular size of 342.2, 342.3 and 397.4 Da respectively. 47 In 
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addition, sugar markers are biologically safe for use in humans and animals.47 However, 
some of these sugars may be degraded to some degree by digestive enzymes and/or 
luminal bacteria.37  
Sucrose has been used as a marker of gastric barrier function in human beings 
and dogs. Sucrose is rapidly hydrolyzed within the small intestine and, therefore, 
permeability of intact sucrose implies pre-duodenal permeation due to gastric mucosal 
damage.48 The enzyme sucrase isomaltase, located in the brush border of enterocytes of 
the small intestine, hydrolyzes sucrose into glucose and fructose.49 Because sucrose is 
only present intact in the stomach and at the very proximal portion of the duodenum any 
increased of sucrose permeability would suggest gastric ulcers or another gastric 
disease.37  
Lactulose is metabolized exclusively in the colon.37 Therefore, lactulose 
permeability should be specific for the small intestine. Lactulose permeates the small 
intestine through paracellular pores, which are located at the crypt in a low density, 
while rhamnose absorption occurs mainly through transcellular aqueous pores, which are 
present at a higher frequency at the tip of the villi. None of these sugar probes has an 
affinity for carrier-mediated transport. Therefore, the ratio between these two markers is 
an indicator of intestinal mucosal integrity.50 
Intestinal absorptive capacity can be estimated by carbohydrates that undergo 
carrier-mediated absorption, namely D-xylose and 3-O-methyl-D-glucose.14,51 D-xylose 
undergoes passive carrier-mediated transport predominantly in the jejunum, whereas 3-
O-methyl-D-glucose is absorbed by active carrier-mediated (Na-dependent) transport in 
the small intestine.52 The ratio of D-xylose to 3-O-methyl-D-glucose absorption can be 
used to correct for pre- and post-mucosal factors affecting the absorption of these two 
monosaccharides.53 Under physiologic conditions, sucralose, a sucrose molecule in 
which three hydroxyl groups have been replaced with chlorine atoms, passes the entire 
digestive tract without being absorbed. Moreover, sucralose is not metabolized by 
intestinal bacteria.37 Thus, a sucralose permeability test may be used as an indicator of 
permeability of the entire gastrointestinal tract. However, the signal to noise ratio can be 
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high and it may be difficult to assess permeability of the colonic mucosa with these 
markers. 
 
DEVELOPMENT OF GASTROINTESTINAL PERMEABILITY AND 
MUCOSAL FUNCTION TESTS 
In dogs, a combination of various sugars has been used to assess gastrointestinal 
permeability. However; this combination will depend on which part of the 
gastrointestinal tract needs to be evaluated. For example, a 2-sugar protocol, 
simultaneously evaluating the permeability towards lactulose and L-rhamnose can be 
used for evaluation of intestinal permeability.54 A 4-sugar protocol containing lactulose, 
L-rhamnose, methylglucose, and xylose can be used for evaluation of intestinal 
permeability and intestinal absorptive capacity.55 A 5-sugar protocol that simultaneously 
measures lactulose, L-rhamnose, methylglucose, xylose, and sucrose can be used for 
evaluation of gastrointestinal permeability and intestinal absorptive capacity.56 
Regardless of which protocol is chosen, food is withheld the night before the procedure, 
and the bladder is completely emptied via catheterization before sugar administration. 
The sugar probes are dissolved in water and then administered by orogastric intubation.57 
Urine is subsequently collected over a period of six hours. Complete urine collection is 
important for accurate quantification of sugar permeation and absorption. However, 
passage of markers through the gastrointestinal tract and their permeation or absorption 
by the mucosa, as well as the distribution into the vascular space requires a lot of time. 
Therefore, 6 hours has been established as the routine time period to assess 
gastrointestinal permeability and absorptive capacity after oral administration of the five 
sugar markers described above in healthy dogs.58  
Serum or urine concentrations of these markers do not only depend on the 
permeability of the intestinal mucosa. Non-mucosal factors, such as the rate of gastric 
emptying, intestinal transit time, dilution in the intestinal lumen, systemic distribution, 
metabolism, renal elimination, and urine removal all significantly influence the serum 
and urine concentrations for these markers.59 In order to eliminate pre- and post-mucosal 
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factors, the calculation of a ratio of two measured values minimizes the influence of 
these factors to a large extent.60 This is based on the assumption that both markers are 
affected in the same way by these non-mucosal factors. Thus, intestinal permeability is 
expressed as the ratio of the fractional excretion of a large molecule compared to a 
smaller one (for example lactulose to rhamnose).60 That ratio can be interpreted as the 
number of intermediate sized pores as a proportion of the total number of aqueous 
channels.13 As the smaller channels are concentrated at the villus tip, permeation rates of 
compounds across this pathway serve as an estimate of mature small-intestinal surface 
area. Thus, any epithelial damage at that level provides alternate routes for the 
permeation of larger molecules such as lactulose. As a result, an increase in the 
disaccharide/monosaccharide ratio can be observed 13  
 
APPLICATIONS OF GASTROINTESTINAL PERMEABILITY TESTING 
Diseases that have been described as being associated with altered 
gastrointestinal permeability include acute viral gastroenteritis, Clostridium perfringens- 
and Clostridium difficile-associated diarrhea, gluten sensitive enteropathy, IBD, 
intestinal parasitism (e.g. ascarides, Giardia), protein losing enteropathy, small intestinal 
bacterial overgrowth (SIBO), diabetes mellitus, hepatitis, pancreatitis, and 
uremia.61,62,51,63 Also, in several studies, non-steroidal anti-inflammatory drugs 
(NSAIDs) and cytotoxic drugs have been shown to increase gastrointestinal 
permeability.64,65 Also, GI permeability tests may also be used to monitor response to 
therapy. Several studies in humans and dogs have reported the normalization of 
intestinal permeability after appropriate therapy.66,42,67 The evaluation of intestinal 
permeability has been used as an early indicator for the relapse of certain diseases in 
humans, such as Crohn’s disease68 and also in dogs with gluten sensitive enteropathy.69  
As mentioned above, traditionally GI permeability tests for the evaluation of 
mucosal damage in GI disease were set up by collecting urine for several hours and 
measuring urinary recoveries for sugar markers.56 This method is considered time 
consuming and relatively cumbersome for patients and clinicians. In addition, renal 
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dysfunction, hydration status of the patients, and incomplete urine collection can 
potentially introduce methodical errors.70 Moreover, methods using urine are considered 
invasive since some animals require bladder catheterization. All these aspects could be a 
source of error for this type of investigation.71,72 Measurement of permeability markers 
in serum would reduce the problems associated with urinary recovery and may allow for 
the development of faster permeability testing based on the measurement of a single 
serum sample after oral administration of the test markers.  
 
METHODS FOR SEPARATION AND DETECTION OF SUGAR MARKERS 
Gas chromatography (GC), gas chromatography–mass spectrometry (GC-MS), 
high-performance liquid chromatography coupled with pulsed amperometric detection 
(HPLC-PAD)56 or with mass spectrometry (HPLC-MS) have all been reported for the 
simultaneous measurement of sugar probes in urine.73 However, due to the 
physicochemical characteristics of sugars, they have to be converted into a more stable 
metabolite before GC analysis. This is one reason why HPLC-PAD or HPLC-MS are the 
most commonly used methods used for sugar analysis today. However, most detection 
systems coupled to HPLC have some technical drawbacks. For instance, refractive index 
(RI) based methods and evaporative light scattering detectors (ELSD) have poor 
selectivity due to the universal detection of compounds. Fluorescence based detection 
methods require fluorescent compounds, which are not available for sugar probes. 
Electrochemical detection, in particular PAD, is more suitable due to a higher sensitivity, 
though it also has low detection selectivity.74  
More recently, liquid chromatography (LC) coupled with electrospray ionization 
mass spectrometry (MS-ESI) has emerged as an alternative to overcome earlier problems 
with HPLC methods; however, this method has a low selectivity to cover a full range of 
metabolites. you are not trying to measure anything in a cell.75,76 However, the literature 
demonstrates many examples where sugar analysis by GC-MS can be employed to 
enhance the sensitivity of sugar analysis because of its sensitivity and selectivity for 
biological constituents.77   
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Determination of metabolites containing hydroxyl and carbonyl functional 
groups requires derivatization before they can be analyzed by GC-based methods. 
Changes of the chemical structure are required to convert sugars into more volatile 
derivatives that are able to resist the high vapor pressure and temperatures of GC.78 Such 
characteristics are achieved by reducing the polarity of functional groups. This results in 
a more thermally stable and volatile metabolite.79  
The most common way to derivatize sugars that have functional groups, such as 
–OH, is to add a trimethylsilyl (TMS) group to form TMS-ether derivatives. TMS-ethers 
of mono- and disaccharides are easily prepared and separated chromatographically.78 
However, TMS-derivatization of monosaccharides often results in the formation of 
multiple peaks in the GC chromatogram due to their cyclic anomers resulting in five 
tautomeric forms of the reduced sugar.80  
However, by converting the aldehyde- and keto-groups into oximes using 
hydroxylamine before the formation of the TMS groups eliminates the possibility of 
cyclic forms, resulting in the formation of only syn and anti structures. Several 
derivatization protocols can be used to produce both oximation and silylation reactions. 
Some advantages of TMS derivatization methods include the relative ease and rapid way 
to transform hydroxyl and carbonyl groups into the oxime and silyl derivatives.81  
BSTFA is a strong trimethylsilyl group donor and has demonstrated good silylation 
when combined with different catalyzing compounds such as pyridine and TMCS79 
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HYPOTHESIS AND SPECIFIC OBJECTIVES  
The hypothesis of this project was that GC-MS is a sensitive and reproducible 
method that can be utilized to simultaneously detect lactulose, rhamnose, xylose, 3-O-
methyl-D-glucose, and sucrose in canine serum. 
The objectives of the present research project were: to 1) develop and validate a 
GC-MS-based method for the analysis of 5 orally administered sugar markers (lactulose, 
rhamnose, xylose, 3-O-methyl-D-glucose, and sucrose) in canine serum in order to 
establish the best suitable protocol for extraction and derivatization of these 5 sugar 
markers from serum and to establish the gas chromatographic conditions for the analysis 
of the 5 sugar markers in real serum samples; and 2) to analyze the kinetic profiles of 
lactulose, rhamnose, xylose, 3-O-methyl-D-glucose, and sucrose in serum of healthy 
dogs in order to establish the best time-point for collection of blood samples after an 
orogastric administration of a solution containing these 5 sugar probes. 
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CHAPTER II 
 
DEVELOPMENT AND ANALYTICAL VALIDATION OF A GAS 
CHROMATOGRAPHY-MASS SPECTROMETRY METHOD FOR THE 
MEASUREMENT OF SUGAR PROBES IN CANINE SERUM 
 
OVERVIEW 
The  study aim was to develop and analytically validate a gas chromatography-
mass spectrometry (GC-MS) method for the quantification of lactulose (L), rhamnose 
(R), xylose (X), 3-O-methylglucose (M), and sucrose (S) in canine serum. Pooled serum 
samples from healthy dogs were spiked with these sugars at concentrations 3, 30, 100, 
and 350 mg/L. Mannitol was added as an internal standard. Serum samples were 
precipitated with methanol, derivatized to produce trimethylsilyl derivatives and then 
analyzed by GC-MS. The method was analytically validated by determination of 
dilutional parallelism, spiking recovery, intra-assay variability, and inter-assay 
variability. Standard curves ranging from 0.5 to 500 mg/L for each sugar showed a mean 
r² of 0.997. The lower detection limit was 0.03 mg/L for L, R, M, and X, and 0.12 mg/L 
for S. The observed/expected ratios (O/E ratios) for dilutional parallelism had a mean ± 
SD of 105.6 ± 25.4% at dilutions of 1 in 2, 1 in 4, and 1 in 8. The analytical recoveries 
for the GC-MS assays of sugars had a range from 92.1% to 124.7% (mean ± SD 106.2 ± 
13.0%). Intra-assay coefficients ranged from 6.8% to 12.9% for lactulose, 7.1% to 
12.8% for rhamnose, 7.2% to 11.2% for xylose, 8.9% to 11.5% for methylglucose, and 
8.9% to 12.0% for sucrose. Inter-assay coefficients of variation ranged from 7.0% to 
11.5% for lactulose, 6.4% to 9.4% for rhamnose, 6.8% to 13.2% for xylose, 7.0% to 
15.9% for methylglucose, and 5.5% to 9.4% for sucrose. The GC-MS method described 
here is accurate, precise and reproducible for the simultaneous measurement of sugar 
markers in serum. 
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INTRODUCTION 
 The assessment of gastrointestinal mucosal permeability and absorptive capacity 
provides information about gastrointestinal mucosal function. Non-metabolizable 
markers, such as polyethylene glycol, sugars, or radiolabeled substances have been 
widely used.82 Altered intestinal permeability has been reported in humans with 
inflammatory bowel disease (IBD) and also in animals with experimental 
gastrointestinal disease.83 In humans and dogs, intestinal permeability generally 
increases with the severity of the disease.84’63 Intestinal permeability has even been 
postulated to be responsible for the introduction of antigenic or infectious agents through 
the intestinal mucosa, leading to excessive immunogenic stimulation.85’86 
 Today mono- and disaccharides are widely used to assess abnormalities of 
gastrointestinal permeability and mucosal absorptive capacity.50 With the exception of 
mannitol, which is believed to be synthesized in only small quantities in humans,43 but is 
not believed to be synthesized in animals,87 both groups of sugars probes (mono- and 
disaccharides) are not considered to be endogenously synthesized in mammalian 
species.43 Therefore, serum concentrations of these sugars are considered to exclusively 
originate from gastrointestinal permeability. The use of a mixture of mono- and 
disaccharide markers is based on the assumption that the intestinal epithelium is a 
heteroporous layer.11 Aqueous pores are distributed along the crypt-villus axis of the 
small intestinal mucosa. Small channels (radius <6 ) are relatively abundant at the tips 
of the villi, allowing the permeation of small molecules such as rhamnose, but excluding 
the passage of larger molecules, such as lactulose.12 Therefore, molecules of the size of 
disaccharides (e.g., lactulose) are restricted from moving across the villus tip, whereas 
monosaccharides, such as rhamnose, can do so through passive diffusion. In contrast, 
while the monosaccharide mannitol is also absorbed by simple diffusion, it does not 
move freely across the villus tip. The largest channels (50-60 ) are paracellular, exist in 
low abundance and are located in the crypts.13 These paracellular pathways at the level 
of the tight junctions in the crypts are thought to be the route of permeation for 
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disaccharides such as lactulose, while the transcellular pathway at the level of the villi is 
thought to be the main route for permeation of monosaccharides.12’88 
 Rather than using a single permeability probe, often times a mixture of probes is 
being utilized. One advantage of using a mixture of different probes is that different 
probes remain intact only in specific compartments of the GI tract and this can help to 
localize the intestinal damage.37 Class 1 probes (e.g., sucrose) are broken down upon 
entering the small intestine. Class 2 probes, such as lactulose and mannitol, pass through 
the stomach and the majority of the small bowel before undergoing bacterial degradation 
in the distal small intestine and especially the colon. Class 3 probes (e.g., Cr-EDTA and 
PEG) do not undergo metabolism or bacterial degradation and remain intact throughout 
the entire length of the gut.37 However, because these markers permeate the 
gastrointestinal mucosa throughout its entire length the signal to noise ratio can be high 
and it may be difficult to assess permeability of the colonic mucosa with these markers. 
   Absorptive capacity of the intestinal mucosa can be measured effectively by use 
of non-metabolizable carbohydrates such as rhamnose, which is believed to permeate the 
gastrointestinal mucosa by the passive transcellular route, and thus permeability of this 
sugar is dependant on mucosal surface area.89 Other carbohydrates that undergo passive 
and active carrier-mediated transport include D-xylose and 3-O-methyl-D-glucose 
respectively.14,51 D-xylose is not absorbed by the intestine via a passive carrier (GLUT2 
or GLUT5), but  has a low affinity for the sodium dependent carrier SGLT-1 
predominantly in the jejunum.90,91 In contrast, 3-O-methyl-D-glucose is absorbed by 
active carrier-mediated transport (Na+-dependent) throughout the small intestine.92 These 
sugars are not metabolized and, after intravenous administration, are excreted intact in 
the urine.53  
Many different protocols for assessment of intestinal permeability and mucosal 
function have been developed.14,43 To date, protocols utilizing permeability markers 
excreted and recovered in urine are the most widely used.58
 
Such protocols require 
complete urine collection over a period of 4 to 24 hrs, which is laborious and often 
impractical.  Furthermore, incomplete urine collection may affect test results.93
 
Thus, the 
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measurement of carbohydrate markers in serum would simplify assessment of intestinal 
permeability and absorptive function under clinical conditions, because serum samples 
can be obtained more easily in a practice setting.  
Several methods for the quantification of carbohydrates in serum samples have 
been described. For example, sucrose has been measured in human serum using an 
enzymatic method.94 In horses, a high performance liquid chromatography coupled to 
mass spectrometry (HPLC-MS) method has been used to measure sucrose in serum.95 
Measurement of 3-O-methyl-D-glucose in human serum has been reported using thin 
layer chromatography and densitometry.96 Lactulose and mannitol have been measured 
in human serum using HPLC and pulsed amperometric detection (PAD).93 Finally, in a 
recent study HPLC-PAD was used for the measurement of lactulose, rhamnose, 3-O-
methyl-D-glucose, and xylose in dog serum.97 For most detection systems coupled to 
HPLC some problems have been observed. For instance, refractive index (RI) based 
methods and evaporative light scattering detectors (ELSD) have poor selectivity due to 
universal detection of compounds, and fluorescent detection based methods require 
fluorescent compounds, which are not available for sugar probes. Electrochemical 
detection, in particular PAD, is more acceptable due to higher sensitivity, though it also 
has low detection selectivity.74 Also, HPLC and PAD detection is not useful to directly 
analyze complex biological samples, such as serum, and serum proteins and lipids must 
be removed before analysis.  
The use of gas chromatography - mass spectrometry (GC-MS) is considered to 
be a suitable method for the quantification of sugar probes, because of the high 
sensitivity of this method.81 The resolution obtained with GC-MS results in good peak 
capacity, which is defined as the maximum number of non-overlapping peaks in a given 
interval.81 GC-MS methods have been previously described for the quantification of 
carbohydrates in urine,98’73 plasma,99 aqueous solutions,100 environmental samples, food 
products,101 and serum.102’ 103  
The aim of this study was to analytically validate a GC-MS-based method for the 
simultaneous quantification of lactulose (L), rhamnose (R), xylose (X), methylglucose 
 17 
(M), and sucrose (S) in order to assess gastrointestinal permeability and intestinal 
absorptive function in an accurate, fast, and practical fashion that could facilitate its use 
in research and clinical practice. 
 
MATERIALS AND METHODS  
Standard solutions. Stock solutions of individual sugar probes (L, R, M, X, and 
S)a were prepared by dissolving a mixture of all sugars in pooled canine serum from 
approximately 200 healthy dogs. Eleven standard solutions (i.e., 500.0, 250.0, 125.0, 
62.5, 31.3, 15.6, 7.8, 3.9, 2.0, 1.0, and 0.5 mg/L) were prepared for each of the 5 sugars 
by serial dilution of 1 in 2. Mannitol was used as an internal standard and was added to 
each standard solution in a final concentration of 100 mg/L.   
Calibration curves were established by plotting the ratios of the area under the 
curve of the peaks of the sugars of interest to that of the internal standard for the 
different standard solutions using a polynomial curvilinear regression (y = ax2 + bx + c). 
The sugar peak area ratios of unknown serum samples were then extrapolated from the 
calibration curves. 
Sugars extraction and derivatization. Serum aliquots of 200 L were mixed 
with 22.2 L of an aqueous internal standard solution (mannitol in a final concentration 
of 100 mg/L) in 2-ml plastic vials. Then, 600 L of methanolb was added to each serum 
sample and mixed for 20 seconds using a vortex mixer. Samples were then centrifugedc 
at 2,655 g for 7 minutes and the protein-free supernatants were transferred into 4-ml 
molded screw cap glass vials.d Samples were evaporated to dryness under a stream of 
nitrogen in a heating modulee at 64°C for 30 min. Once the tubes were cooled, the dried 
residue was derivatized in a two-step procedure. First, 50 L of Mox reagent (2% of 
Methoxyamine-HCl in pyridine)f and 70 L of pure pyridinef were added to each tube. 
Tubes were capped and vortexed for 20 seconds and subsequently heated in a microwave 
for 2 min to promote the oximation reaction.104 Then, samples were allowed to cool for 5 
min and 100 L of a N,O-bis[Trimethylsilyl]trifluoroacetamide (BSTFA)f containing 1% 
TMCS was added to each tube. The tubes were capped, vortexed for 20 seconds and 
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placed in a microwave for an additional 5 min to develop the silylation reaction 
according to the procedure described by Silva et al.104 Once the samples were cooled at 
room temperature, derivatized extracts were evaporated to dryness under a nitrogen 
stream at 64°C for 8 minutes and the residues were dissolved in 250 L of hexane.g GC-
MS analysis was performed with 1 µl of this solution.  
Gas chromatography. Derivatized samples were analyzed using gas 
chromatographyh coupled with a mass spectrometer.h The 1 µL aliquots of the extracts 
were injected into a split/splitless inlet, operated in splitless mode, at an inlet 
temperature of 250°C. Separation of sugars was achieved using a DB-1MS capillary 
columnh (30 m length, 250 m inner diameter, and 0.25 m film thickness). The 
following GC column temperature program was used: the initial oven temperature was 
set at 100°C and held for 5 minutes. Temperature was then increased from 100 to 325°C 
by a constant gradient of 15°C/min and held at 325°C for 5 min, resulting in a total run 
time of 23.33 min per sample. Helium was used as a gas carrier at a constant flow rate of 
1.5 mL/min at a velocity of 33 cm/sec. The qualitative analysis was performed under 
full-scan acquisition mode within an m/z 50 to m/z 1050 range. Quantification of sugar 
concentrations was performed by using the sum of peak areas from specific retention 
times of each sugar using selected ion monitoring (SIM) mode. The selected ions for the 
sugars were: m/z 204, for lactulose, m/z 117, for rhamnose, m/z 147 for methylglucose, 
m/z 217 for sucrose, m/z 217 for xylose, and m/z 217 for mannitol. 
Chromatograms. The derivatization procedure was evaluated by comparing the 
area under the curve for peaks generated from spiked serum samples with those 
generated from the same amount of the pure compound previously analyzed under the 
same derivatization and gas chromatography conditions. Sugars were identified by 
matching their chromatographic retention times and their characteristic mass spectrum 
(Table 1). In order to verify interference by other carbohydrates, an aqueous solution 
containing glucose, fructose, fucose, and sucralose as well as mannitol (used as an 
internal standard) lactulose, rhamnose, methylglucose, xylose, and sucrose, was 
analyzed. Figure 1 illustrates the chromatogram obtained from the analysis of a pooled 
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serum sample. In this chromatogram, no peak with a retention time of 14.06 (retention 
time of mannitol) was observed. This would indicate that mannitol is not present at 
detectable concentrations in canine serum. In contrast, figures 2 and 3 illustrate the 
chromatograms of a five sugar standard solution and an unknown canine serum sample, 
respectively, to which mannitol (m) has been added.  
Validation. The method was validated by evaluating spiking recovery, dilutional 
parallelism, intra-assay variability, and inter-assay variability. For spiking recovery 
(accuracy of the assay), four different pooled serum samples obtained from healthy dogs 
were spiked with each sugar to reach a final serum concentration of 3 mg/L (sample A), 
30 mg/L (sample B), 100 mg/L (sample C), and 350 mg/L (sample D), respectively. For 
dilutional parallelism (linearity of the assay), the spiked serum sample containing 350 
mg/L (sample D) of each of the sugars and an unknown sample were diluted 1 in 2, 1 in 
4, and 1 in 8 with canine serum. The results for spiking recovery and dilutional 
parallelism were expressed as observed to expected (O/E) ratios.  
The 4 spiked serum samples (samples A through D) mentioned above were used 
to evaluate the precision and the reproducibility of the assay. To determine precision, 
intra-assay variability was assessed by running these 4 serum samples spiked with 
different concentrations of the five sugars probes 9 consecutives times within a single 
GC-MS run. Coefficient of variation was calculated for all five sugars. To determine 
reproducibility, inter-assay variability was evaluated by running the 4 serum samples 
spiked with different concentrations of the five sugar probes 9 times on different days.   
 
RESULTS  
 Table 1 shows the GC-MS characteristics for all sugar probes. The retention 
times and the underlined m/z values belong to the peaks and the major ions, respectively, 
which were used for quantification. The rest of the ions are those observed according to 
the fragmentation pattern detected in full-scan MS mode used for the identification of 
the carbohydrates (chromatogram not shown). The mass spectra of the analyzed 
carbohydrates were dominated by ions at m/z 73, 117, 147, 204, 217, 361, 437, and 451, 
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and the retention times (RT) were constant at the GC conditions and derivatization 
procedures performed in this study. Figures 4 to 8 show the chromatograms for the 
individual sugars analyzed in SIM mode. The insets in the graphs show the SIM mass 
spectra with the respective quantification ion for each sugar. Fig. 4 shows the 
chromatogram for lactulose. A minor peak eluted at 18.01 min, whereas the two main 
peaks eluted at a RT of 18.42 and 18.44 min, respectively. 
 The inset graph shows the ion with m/z 204, which was used for analysis and 
quantification of this disaccharide. The sucrose chromatogram in Fig. 5 shows a minor 
peak at a RT of 17.84 min, while the prominent peak is found at a RT of 18.12 minutes. 
While sucrose and lactulose had peaks with RT and m/z close to each other, the 
derivatization protocol used in the present study achieved sufficient and consistent 
separation of these two compounds for the differentiation of these two carbohydrates. 
Fig. 6 displays the chromatogram for rhamnose showing peak RTs of 12.43 and 12.50 
min. The chromatogram in Fig. 7 shows the chromatogram and RTs of xylose. Fig. 8 
shows the chromatogram for methylglucose containing the selected ion at m/z 147. 
These m/z are in agreement with previous reports using the same derivatization reagents. 
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Table 1:  Characteristics of sugars analyzed by GC-MS as TMS derivatives. Retention 
time indicates where chromatogram peaks of each sugar are located. The m/z depicts the 
GC-MS fragmentation ion pattern of each sugar. The m/z of the peaks selected for 
quantification of the sugars is underlined. 
      Sugar                          Molecular             Retention                        m/z 
                                             mass            time (min) 
      Lactulose                       342           18.01, 18.42,             73, 147, 204, 361 
      Sucrose                       342           17.75, 18.12                   73, 217, 361, 437 
      Xylose                             150           11.84, 11.90                   73, 147, 217, 307 
      Rhamnose                  164                  12.45, 12.50                   73, 117, 219, 277 
      Methylglucose               194                  12.70, 13.16, 13.45        73, 147, 205, 262 
      Mannitol                       182                  14.06                              73, 205, 217, 319 
The m/z of the peaks selected for quantification of the sugars is underlined. 
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Figure 1: Total ion chromatogram for a blank serum sample. The chromatogram 
shown here is from a blank sample from pooled canine serum  
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Figure 2: Total ion chromatogram for a five sugars standard solution. The 
chromatogram shown here is from analysis of a serum standard containing 125 mg/L of 
xylose (X), rhamnose (R), 3-O-methyl-D-glucose (M), sucrose (S), lactulose (L), and the 
internal standard mannitol (m). 
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Figure 3: Total ion chromatogram of an unknown sample. The chromatogram shown 
here is from analysis of an unknown serum sample containing mannitol as internal 
standard (m). 
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Figure 4: GC/MS chromatogram for lactulose. In the selected ion chromatogram on 
the left the numbered peaks indicate the retention times for the derivatized ions of 
lactulose. The smaller chromatogram on the right depicts the mass spectrum of the TMS-
derivative of lactulose at m/z 204. 
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Figure 5: GC/MS chromatogram for sucrose. In the selected ion chromatogram on the 
left the numbered peaks indicate the retention times for the derivatized ions of sucrose. 
The smaller chromatogram on the right depicts the mass spectrum of the TMS-derivative 
of sucrose at m/z 217. 
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Figure 6: GC/MS chromatogram for rhamnose. In the selected ion chromatogram on 
the left the numbered peaks indicate the retention times for the derivatized ions of 
rhamnose. The smaller chromatogram on the right depicts the mass spectrum of the 
TMS-derivative of rhamnose at m/z 117. 
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Figure 7: GC/MS chromatogram for xylose. In the selected ion chromatogram on the 
left the numbered peaks indicate the retention times for the derivatized ions of xylose. 
The m/z smaller chromatogram on the right depicts the mass spectrum of the TMS-
derivative of xylose at m/z 217. 
 
 
 
 
 
 
 
 
 
 29 
 
 
 
Figure 8: GC/MS chromatogram for methylglucose. In the selected ion 
chromatogram on the left the numbered peaks indicate the retention times for the 
derivatized ions of methylglucose. The smaller chromatogram on the right contains the 
mass spectrum of the TMS-derivative of methylglucose at m/z 147. 
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Figure 9: Standard curves. Representative standard curves of the GC-MS assays for 
the simultaneous determination of five sugar probes in canine serum.  
 
 
 
Table 2:  Calibration curves, linearity detection limits for sugar analysis by GC-
MS. This table shows the m/z of the peak used for quantification of each sugar, the range 
of calibrators used for calculating the standard or calibration curve, linearity, and the 
detection limits when assayed by this GC-MS method.  
Compound      Ion          Calibration curve          Linearity      Lower limit of detection 
                           (m/z)      (mg/L)                 (r²)                     (mg/L) 
 Lactulose      204            0.5 -500              0.9983          0.03 
 Sucrose                217       0.5 -500              0.9996          0.12 
 Xylose                  217         0.5 -500              0.9996          0.03 
 Rhamnose            117                  0.5 -500              0.9991          0.03 
 Methylglucose     147                  0.5 -500              0.9975           0.03 
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Table 3: Spiking recovery. This table shows the recovery of the 5 sugars spiked into 
canine serum at concentrations of 3, 30, 100, and 350 mg/L. The means are expressed as 
observed (O)/expected (E) ratios (O/E %).  
  Expected Observed O/E 
  (mg/L) (mg/L) (%) 
Lactulose 3 3.7 123.3 
  30 34.9 116.3 
  100 97.2 97.2 
  350 338.4 96.7 
   mean 108.4 
    SD 13.5 
Rhamnose 3 4.4 147.7 
  30 43.5 145.1 
  100 112.6 112.6 
  350 326.3 93.2 
   mean 124.7 
    SD 26.4 
Methylglucose 3 3.6 120.1 
  30 25.4 84.7 
  100 88.9 88.9 
  350 313.5 88.3 
   mean 95.5 
    SD 16.5 
Xylose 3 4.3 143.3 
  30 31.7 105.7 
  100 107.5 107.5 
  350 309.2 84.9 
   mean 110.4 
    SD 24.2 
Sucrose 3 1.7 56.7 
  30 34.5 115.1 
  100 111.7 111.7 
  350 297.1 84.9 
   mean 92.1 
    SD 27.2 
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Table 4: Dilutional parallelism.  This table shows the results of dilutional parallelism 
of a blank serum sample spiked with 350 mg/L of all 5 sugar probes (L, R, M, X, and S) 
and of an unknown serum sample. (O/E = (observed/expected)*100) 
 
                    Serum sample (350 mg/L)                 Unknown serum sample 
Dilution O 
mg/L   
E 
mg/L 
O/E (%) Dilution O 
mg/L 
E 
mg/L 
O/E (%) 
Lactulose  Lactulose  
Neat 318.4  Neat    10.2  
1:2 142.7 159.2 89.7 1:2   6.2 5.1 121.2 
1:4  69.4 79.6 87.2 1:4   3.6 2.6 149.0 
1:8  30.7 39.8 77.7 1:8   2.1 1.3 164.2 
Rhamnose  Rhamnose  
Neat 299.4  Neat  63.9   
1:2 166.1 149.7  110.9 1:2  32.0 31.8   100.8 
1:4   81.1 74.9  108.3 1:4  13.7 15.9 86.4 
1:8   38.6 37.4  103.1 1:8   5.4   7.9     67.6 
Methylglucose  Methylglucose  
Neat 330.7  Neat 99.9   
1:2 185.3 165.3 112.1 1:2 49.7 50.0 99.6 
1:4   88.7   82.7 107.3 1:4 23.3 25.0 93.2 
1:8   40.3   41.3   97.6 1:8 10.5 12.5 84.4 
Xylose  Xylose  
Neat 304.1  Neat  106.8  
1:2 160.9 152.1 105.8 1:2  55.5 53.4 104.0 
1:4 76.5 76.0   100.6 1:4 24.1 26.7 90.2 
1:8 36.5 38.0 96.0 1:8 10.9 13.4 81.6 
Sucrose  Sucrose  
Neat 290.2  Neat   2.3   
1:2 154.5 145.1   106.5 1:2   1.3 1.1 110.7 
1:4 84.9 72.5 117.0 1:4  ND   
1:8 41.5 36.3 114.3 1:8  ND   
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Table 5: Intra-assay variability. Four serum samples containing 5 sugars at different 
concentrations were analyzed 9 times within the same assay run. Samples A, B, C, and D 
contained 3, 30, 100, and 350 mg/L of the 5 sugars, respectively. (%CV = (standard 
deviation/mean)*100) 
 
Sample 1 
(3 mg/L) 
Sample 2 
(30 mg/L) 
Sample 3 
(100 mg/L) 
Sample 4 
(350 mg/L) 
Sugar 
mean 
(mg/L) 
CV 
(%) 
mean 
(mg/L) 
CV     
(%) 
mean 
(mg/L) 
CV 
(%) 
mean 
(mg/L) 
CV 
(%) 
Lactulose 3.3 9.1 46.5 7.9 131.9 6.8 281.3 12.9 
Rhamnose 3.4 11.8 43.0 8.9 123.3 7.1 364.9 12.8 
Methylglucose 2.7 11.1 33.7 8.9 125.3 10.8 377.6 11.5 
Xylose 2.9 10.3 38.4 11.0 136.9 7.2 384.0 11.0 
Sucrose 3.1 9.7 26.4 9.4 96.7 12.0 352.5 8.4 
 
 
Table 6: Inter-assay variability. Four serum samples containing 5 sugars at different 
concentrations were analyzed in 9 consecutive assay runs. Samples A, B, C, and D 
contained 3, 30, 100, and 350 mg/L of the 5 sugars, respectively. (CV% = (standard 
deviation/mean)*100 
 
Sample A 
(3 mg/L) 
Sample B 
(30 mg/L) 
Sample C 
(100 mg/L) 
Sample D 
(350 mg/L) 
Sugar 
mean 
(mg/L) 
CV 
(%) 
mean 
(mg/L) 
CV 
(%) 
mean 
(mg/L) 
CV 
(%) 
mean 
(mg/L) 
CV 
(%) 
Lactulose 3.7 7.0 34.9 9.6 97.2 11.5 338.4 8.0 
Rhamnose 4.4 6.9 43.5 7.8 112.6 9.4 326.3 6.4 
Methylglucose 3.6 11.8 25.4 12.4 88.9 15.9 313.5 7.0 
Xylose 4.3 7.3 31.7 13.2 107.5 8.7 309.2 6.8 
Sucrose 1.7 8.1 34.5 9.4 111.7 5.5 297.1 8.1 
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 Assay validation. Fig. 9 shows the calibration curves for the 5 sugar probes 
evaluated. Each sugar standard was prepared with eleven calibration concentrations 
covering the range of expected values in the samples. Within the range of 0.5-500 mg/L 
sugar concentrations were proportional to their integrated peak areas. Similarly, the 
concentration of the internal standard was proportional to its integrated peak area. Due to 
a possible instrument variability and analyte sensitivity (i.e., changes in temperature, 
pressure, and electronic detector), taking a ratio of areas is more reproducible than using 
absolute values for individual compounds. Thus, if we assume that unknown 
samples/sugar standards and internal standards were processed analogously, they were 
exposed to similar factors. Therefore, standard curves established with an internal 
standard minimized the effect of variability from run-to run. Calibration curves used the 
ratio rather than just the peak area of the analytes to be quantified. In this case, the ratio 
of the concentrations of a given unknown and the internal standard is proportional to the 
ration of their peak areas. All curves showed good coefficients of correlation (Table 2). 
The best-fit line for the ratio of integrated peaks against the ratio of concentrations of 
each sugar to internal standard was fitted by polynomial regression. The curves showed 
a mean r² = 0.997 for all sugars. The polynomial second order model used here has the 
advantage over the straight line model that the former integrates an intercept line with 
the experimental background noise of the blank sample. Therefore, with a polynomial 
model, the intercept line runs through zero, which is useful to define detection limits and 
to properly measure unknown samples.105  
 The lower detection limit of the assay was 0.03 mg/L for L, R, M, and X, and 
0.12 mg/L for S. These limits compare favorably with those reported for HPLC-PAD  
analysis (i.e., xylose 0.13 mg/L, rhamnose 0.36 mg/L sucrose 0.02 mg/L, mannitol 0.12 
mg/L,74 and lactulose between 0.4-0.8 mg/L)72’106 or for capillary electrophoresis (i.e., 
10 mg/L for lactulose).107 
 The accuracy of the assay was determined by evaluation of spiking recovery of 
the samples A through D (3, 30, 100, and 350 mg/L) for each sugar in serum (Table 3). 
Observed to expected ratios for spiking recovery of the 5 sugars ranged from 96.7% to 
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123.3% (mean ± SD: 108.4 ± 13.5%) for lactulose, from 93.2% to 147.7% (mean ± SD: 
124.7 ± 26.4%) for rhamnose, from 88.3% to 120.1% (mean ± SD: 95.5 ± 16.5%) for 
methylglucose, from 84.9% to 143.3% (mean ± SD: 110.4 ± 24.2%), and from 56.7% to 
115.1% (mean ± SD: 92.1 ± 27.2%) for sucrose with the mean ranging from.92.1% to 
124.7% (mean ± SD 106.2 ± 13.0%). The linearity of the assay was determined by 
evaluating dilutional parallelism. Table 4 shows the O/E ratios for dilutions of 1 in 2, 1 
in 4, and 1 in 8, which ranged from 67.6% to 164.2% (mean ± SD of 105.6 ± 25.4%). 
Table 5 shows the intra-assay precision with the %CV ranging from 6.8% to 12.9% 
between the individual sugars at 4 different concentrations represented as samples A 
through D. The reproducibility of the assay was determined by evaluating inter-assay 
precision. Results in Table 6 show the % CV which ranged from 6.4% to 15.9% for the 5 
individual sugars at different concentrations. 
 
DISCUSSION 
            Several methods for the measurement of sugar markers in serum and urine for 
gastrointestinal permeability and absorptive capacity assessment have been reported. 
However, some of them are associated with technical drawbacks.108’109’110 Thin-layer 
chromatography is time-consuming,108 while colorimetric/enzymatic methods do not 
provide information on the composition of monosaccharides,109 and HPLC methods are 
considered to have a relatively low sensitivity.110 We developed a GC-MS method that 
determines carbohydrate markers in serum samples from dogs. Mass spectrometry was 
used because of its capability of molecular identification at high sensitivity, based on 
retention time and fragmentation pattern73,76  
 Because saccharides are highly polar and have a low volatility, chemical 
derivatization is required before GC-MS analysis.77,78,111,112 Thus, we converted L, R, M, 
X, and S into more volatile and thermostable sugar-derivatives before analysis. A two 
step derivatization procedure was employed. First, carbonyl groups (-C=O) were 
transformed to more stable and non-polar groups (-C=N-O-CH3) by an oximation 
reaction, which has been previously described.79 This was followed by the formation of 
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trimethylsilyl (TMS) esters using silylating reagents (BSTFA) to replace exchangeable 
protons (-OH) with TMS. The oxime formation is required to eliminate undesirable slow 
and reversible silylation reactions with carbonyl groups, whose products can be 
thermally labile, while silyl derivative groups [-Si(CH3)3] allow measurement of the 
analyte by GC-MS.98 Carbohydrates used in this study produced several GC peaks, but 
only two or four peaks were detectable. Sugars in solution constantly cycle between the 
ring and the straight chain forms, which leads to a dynamic equilibrium between the two 
forms. Therefore, two anomers ( and ) can be formed. If the anomeric center is not 
destroyed by the derivatization procedure, acylation of the aldose ring freezes the 
structure of the  and  anomeric form, producing multiple peaks from one compound 
during GC analysis.113 
 When multiple peak profiles are generated on the GS-MS chromatogram, 
analysis is performed using the standard references previously generated, which contain 
both the retention time and mass spectra. Formation of anomers can potentially be 
avoided by preparing the alditol acetate derivative through treatment with sodium 
borohydride.73 The alditol acetate derivate can then be separated after derivatization with 
dry pyridine and acetic anhydride, which will lead to a single peak for some sugars.73 
However, the alditol acetate derivative method is more suitable for reducing end sugars 
such as glucose, fructose, and lactose,114 which are normally present in serum. 
Moreover, glucose and fructose generate other alditols, such as mannitol and glucitol 
hexa-acetate.114 Therefore, the alditol derivative method was not suitable for the 
measurement of our sugar probes due to the generation of more sugar derivatives from 
glucose, fructose and lactose, which are normally present in serum. Finally, many steps 
are required for a complete and effective reduction of sugars to their alditol acetate 
derivatives.115 Thus, the number of peaks and their retention times are characteristic 
features of each carbohydrate, and are also dependent on the derivatization conditions. 
Peaks can vary in intensity. Small peaks are part of the sugar fragmentation pattern. 
They are a constant fraction of the major peak due to production of multiple silyl 
derivative.98 Therefore, they can be used for the sugar quantitation.116’117 As described 
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above, the quantification of sugar probes was performed by using the sum of the peak 
areas from specific retention times of each sugar using select ion monitoring (SIM) 
mode for specific ions of each sugar as is showed in table 1.  
 The saccharides used in this study showed ions at m/z 73, 147, 191, 204, 205, 
217, 219, 307, and 319, which are in agreement with those previously reported for TMS 
derivatives of rhamnose, xylose, lactulose, and sucrose in specimens other than serum or 
urine (e.g., environmental samples and model solutions).76,118 Similarly, disaccharides 
show a peak at m/z 361, which is typically found as part of the fragmentation pattern of 
these compounds. Also, ions at m/z 437 and m/z 451 are typical for sucrose and 
lactulose, respectively.76  
 Observed to expected ratios for all 5 sugars spiked into serum at the 4 
concentrations ranged from 92.1% to 124.7% (mean ± SD 106.2 ± 13.0%) for all sugars. 
The results of these spiking recovery experiments showed an increased variability for 
rhamnose and xylose at the lowest concentrations. These variations were observed as an 
effect of a wide range of the standard curves used for the method validation. However, 
when a sugar test is performed, xylose and rhamnose are found in significantly higher 
concentrations in healthy and disease states, with concentrations well within the linear 
mid-range of the standard curve. Thus, the effect of high variation in the lower range is 
not important for the assay performance for analysis of clinical samples. Suboptimal 
recovery rate was observed at the lowest spiking concentration of 3 mg/L. This was 
especially the case for the recovery of sucrose. Low accuracy for detection and 
quantification of sucrose at small concentrations compared with higher concentrations 
has been reported using gas chromatography.119 Recovery can be influenced by loss of 
the analyte during extraction and oximation derivatization. Sucrose degradation may 
occur as result of the extraction method and oxime derivatization.120 The %CV for intra-
assay variability for the 5 sugars ranged from 6.8% to 12.9% in the 4 samples evaluated. 
Finally, inter-assay precision was 6.4% to 15.9% for all sugars in the 4 different serum 
samples.  
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 In conclusion, a GC-MS method was successfully developed for the 
simultaneous quantification of lactulose, rhamnose, methylglucose, xylose, and sucrose 
in dog serum. Gas chromatographic conditions and sugar derivatization by converting 
the relative oximes before the silylating reaction showed acceptable linearity, precision, 
and reproducibility to be used for further studies of intestinal permeability and mucosal 
function testing. However, the accuracy of the assay was limited for low concentrations, 
especially for sucrose. 
Notes 
a. D-(+)-Xylose (C5H10O5), D-Sucrose (C12H22O11), D-Lactulose (C12H22O11), L-
Rhamnose monohydrated (C6H12O5 ·H2O), 3-O-Methyl-D-glucopyranose (C7H14O6), D-
Mannitol (C6H14O6), Sigma-Aldrich, St Louis, Mo. 
b.  Methanol, EDM Chemicals Inc. Gibbstown, N.J. 
c.   Centrifuge 5417C, Eppendorf, Brinkmann Instruments Inc, Westbury, N.Y. 
d.  Glass vials molded screw cap, VWR International, West Chester, Pa.  
e.  Reactive therm III, Heating module. Pierce, Rockford, Ill. 
f. N,O-bis[Trimethylsilyl]trifluoroacetamide (BSTFA) 1% TMCS, MOX Reagent (2% 
Methoxyamine•HCL in pyridine), Pyridine, Pierce, Rockford, Ill. 
g.  Hexane, EDM Chemicals Inc. Gibbstown, N.J. 
h. Gas chromatograph (6890N GC) coupled with Mass Spectrometer (5975 MSD) and 
DB-1MS capillary column (122-0132), Agilent Technologies, Palo Alto, Calif. 
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CHAPTER III 
 
KINETIC ANALYSIS OF FIVE SUGAR PROBES IN DOG SERUM AFTER 
OROGASTRIC ADMINISTRATION* 
 
OVERVIEW 
The study aim was to describe the kinetic of sugar probes in serum for the 
assessment of gastrointestinal permeability and intestinal absorptive capacity in eight 
healthy dogs. Based on their body weight, dogs received specific amounts of a mixed 
solution containing lactulose (L), rhamnose (R), methylglucose (M), xylose (X), and 
sucrose (S) by orogastric intubation. Baseline blood samples were taken before dosing. 
Subsequently, timed blood samples were collected during 24 hours. Sugars in serum 
were assayed by the analytically validated gas chromatography-mass spectrometry (GC-
MS) method described in chapter II. Sugar concentrations in serum were quantified 
using an internal standard. Statistical analysis was performed using a Friedman test with 
Dunn’s multiple comparison post test and a Kruskal-Wallis test. Statistical significance 
was set at a p-value <0.05. Sugars in serum were detected in all dogs after administration 
of the test dose (p<0.0001). Concentrations of L and R were significantly different from 
the baseline between from 90 to 240  and 60 to 300 min respectively, and those of X, M, 
and S were different between 30 and 240 min post dosing (p<0.05 for all 5 probes). 
Maximum concentrations of L and R were obtained at 180 min, while X, M, and S 
reached their maximum concentrations at 90 min post dosing. For all sugars, no 
statistically significant differences were found between concentrations at 90, 120, and 
180 min or between the coefficients of variation (%CV) of the mean concentrations for 
these 3 time points. 
 
_________________ 
*Reprinted with permission from Rodríguez H, Suchodolski J, Berghoff N, Steiner JM. 
2008. Kinetic Analysis of five sugar probes in dog serum after orogastric administration. 
Can J Vet Res. (in press). 
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Based on these data, the collection of two blood samples, one taken at baseline 
and a second sample obtained between 90 and 180 after dosing, might be sufficient for 
the determination of all five sugar probes in canine serum. 
 
INTRODUCTION  
The gastrointestinal tract (GIT) provides barrier and transport functions 
preventing the passage of pathogens, toxins, and other luminal contents to extra-
intestinal tissues while selectively absorbing essential nutrients. Such functions can be 
assessed via intestinal permeability testing for macromolecules which are passively 
diffused or absorbed via carrier-mediated transport.43 Permeation and absorption of 
solutes through the gastrointestinal epithelium are determined by the structure of the 
membrane, the physicochemical properties of the solute, and its interaction with the 
media or solvent.82  
Approximately 90% of the absorption in the GIT occurs in the small intestine 
while the rest is carried out by the colon and the cecum. The enterocyte is the most 
abundant cell type with a surface area of approximately 2 X 106 cm2, due to surface-
amplification through villi and microvilli.6’1 
The route by which a compound crosses the intestinal epithelium is transcellular 
(small pores) or paracellular (large pores). Transcellular absorption from the lumen to 
the blood requires carrier mediated transport. The paracellular permeability depends on 
the regulation of intercellular tight junctions which consist of channels formed by 
adjacent enterocytes. Only a small number of compounds can cross the paracellular 
space due to the fact that the surface area available for these channels is estimated to 
only be about 0.01% of the total surface area of the small intestine.121’122  
Three distinct pores are present along the crypt-villus axis, which affect GIT 
permeability due to molecular size restrictions.123 At the tips of the villi, there is an 
abundance of small pores (radius <6 ), while in the crypts much larger pores (50-60 ) 
are found in low density. Intermediate sized (10-15 ) channels, which are not exposed 
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to luminal content, can be found at the base of the villi. Thus, tight junctions of the villus 
epithelium are more restrictive than those in the epithelium of the crypts.121  
This prevents molecules of the size of disaccharides (e.g. lactulose) from moving 
across the villus tip; whereas, monosaccharides like mannitol can cross with relative 
freedom.13 The epithelial junctions become progressively tighter from the small intestine 
to the colon, decreasing the permeability to polar compounds along the intestinal tract.21 
Disorders of the intestinal barrier tend to decrease the transcellular permeability 
reflecting a diminished number of mucosal cells; whereas, paracellular permeability 
tends to increase, reflecting damage to the tight junctions.123’124 According to a review 
by Cave et.al., an increased intestinal permeability has been reported in several intestinal 
diseases in dogs and cats, including gluten sensitivity enteropathy, small intestinal 
bacterial overgrowth, intestinal ischemia-reperfusion, and non-steroidal  anti-
inflammatory drug-induced injury.125 
Intestinal permeability is assessed by measuring urinary excretion of orally 
administered water-soluble, non-degradable test molecules. The test compares the 
intestinal permeation of larger molecules which occurs only between cells at or near the 
crypts with smaller molecules which are normally absorbed along the entire crypt-villus 
axis.43 Calculation of a ratio of the large to the small marker molecule reduces the 
potential influences of pre-mucosal, mucosal, and post-mucosal factors.43,126 An 
increased ratio could reflect an increase in the paracellular permeability due to factors 
such as loss of villus height, which would allow an amplified permeation through the 
larger pores formed by adjacent crypt cells.88  
The most commonly used markers for permeability tests are mono- and 
disaccharides, 51Cr-EDTA, polyethylene glycols (PEGs), and dextran. Inert sugars, such 
as lactulose and L-rhamnose, are commonly used as markers of small intestinal 
permeability. While lactulose permeates through paracellular pores of low frequency and 
L-rhamnose crosses the intestinal epithelium mainly by transcellular passive diffusion 
through aqueous pores at a much higher rate, but neither lactulose nor rhamnose undergo 
carrier-mediated transport.43’14 D-xylose and 3-O-methyl-D-glucose are non-metabolized 
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monosaccharides that are absorbed by the intestinal epithelial cells via carrier-mediated 
transport and they are commonly used as markers of intestinal absorptive capacity. D-
xylose undergoes passive carrier mediated  transport, principally in the jejunum; 
whereas; whereas 3-O-methyl-D-glucose is absorbed by active carrier transport 
throughout the small intestine.127 Finally, sucrose has been introduced as a probe to 
measure gastric mucosal permeability. Sucrose is hydrolyzed in the very proximal small 
intestine, and thus the presence of the intact sucrose in serum or urine implies pre-
duodenal permeation due to gastric mucosal damage.128  
Several methods for the assessment of intestinal permeability and mucosal 
absorption have been developed.14,43 To date, protocols utilizing permeability markers 
excreted and recovered in urine are the most widely used.58 However, these protocols 
require complete urine collection over a period of at least 4 hrs and sometimes up to 24 
hrs. These methods are laborious and often impractical. Also, errors may be introduced  
through  incomplete urine collection, which may affect the test results.93 
 The measurement of carbohydrates in serum would simplify the assessment of 
intestinal permeability and absorptive function under clinical conditions. Some GI 
permeability studies using different sugar markers in serum have been reported. For 
instance, sucrose has been measured in serum by an enzymatic method for the detection 
of gastric damage in humans,94 and was also used for the assessment of gastric 
permeability in horses with gastric ulceration using a high performance liquid 
chromatography-mass spectrometry (HPLC-MS) method.95 Determination of  3-O-
methyl-D-glucose in serum has been performed as a measure of gastric emptying time 
using thin layer chromatography and densitometry.96 Lactulose and mannitol have been 
measured in serum for the assessment of intestinal permeability in humans.93 Finally, a 
recent study has described assessment intestinal permeability and absorptive capacity  in 
dogs  using an HPLC-based method for the measurement of lactulose, rhamnose, 3-O-
methyl-D-glucose, and xylose in serum.97 However, there is limited experience using 
these assays in serum with gas chromatography-mass spectrometry (GC-MS) for the 
assessment of intestinal permeability and absorptive function. An essential advantage of 
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using GC-MS would be an improved sensitivity when compared to HPLC-MS methods. 
We have recently analytically validated a GC-MS method for sugar analysis in serum 
.
129
 Due to improved sensitivity and specificity obtained from the GC-MS method 
relative to previously mentioned assays, this method appears to be superior to previous 
method for carbohydrate analysis for gastrointestinal permeability and mucosal function 
testing.116 However, analysis of any polar, nonvolatile substance, such as sugars, by GC-
MS requires derivatization prior to analysis. 
  The aim of this study was to simultaneously analyze the kinetics of D-(+)-Xylose 
D-Sucrose, D-Lactulose, L-Rhamnose monohydrate, and 3-O-Methyl-D-glucopyranose 
in serum from healthy dogs.  
  
MATERIALS AND METHODS  
This study was approved by the University Animal Care and Use Committee 
(ULAC) at the College of Veterinary Medicine and Biomedical Sciences at Texas A&M 
University. Gastrointestinal permeability and absorption tests were performed in 8 
healthy research dogs. All animals were adults between 2 and 7 years of age. All dogs 
were monitored on a daily basis, and none showed any history related to gastrointestinal 
tract disease. The overall health status of the dogs was assessed by a baseline analysis of 
complete blood count and serum biochemistry analysis. The permeability and absorption 
test protocol required a 48 h period before the test in which the dogs did not receive any 
agent that could alter small bowel permeability. Dogs were kenneled in individual cages 
5 days before the experiment. To ensure that no dietary sugars would be present in the 
serum, food was withheld for at least 18 hours prior to the gastrointestinal permeability 
and absorption tests. 
Hyperosmolar solutions may cause gastrointestinal side effects, such as 
diarrhea.130 In addition, gastrointestinal permeability has been shown to be altered by 
either hypo- or hyperosmolar silutions.131,132 Therefore, all dogs received an 
approximately isoosmolar sugar solution (318.3 mosm/L). In order for the dogs to 
receive similar amounts of sugar per body weight the volume of the sugar solutions used 
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was roughly modified based on body weight. Thus, dogs received either 100 ml (dogs 
less than 10 kg body weight), 200 ml (dogs 10-20 kg body weight), or 400 ml (dogs with 
a body weight of more than 20 kg) of a solution containing sterile water, 10 g/L of 
lactulose (L-7877; Sigma Chemical Company, St. Louis, Missouri, USA), 10 g/L of L-
rhamnose (R-3875; Sigma Chemical Company) (rhamnose), 10 g/L of D(+)xylose (X-
1500; Sigma Chemical Company) (xylose), 5 g/L of 3-O-methyl-D-glucosepyranose (M-
4879; Sigma Chemical Company) (methylglucose), and 40 g/L sucrose (S-9378; Sigma 
Chemical Company) by orogastric intubation. A baseline blood sample was obtained 
from each dog. After the sugar solution was administered, further blood samples were 
taken at 30, 60, 90, 120, 180, 240, 300, 360, 420, 480, 720, and 1440 min post-
administration from the jugular vein. Serum was separated immediately by 
centrifugation at 3000 x g for 10 min. Serum samples were then transferred to collection 
tubes and stored at -80°C.   
Sample preparation. Stock solutions of carbohydrate standards (1 mg/mL) were 
prepared in serum and stored at -20°C. Mannitol (M-9546 Sigma Chemical Company) 
was used as an internal standard and was added at a concentration of 100 mg/L to serum 
samples, blank samples, and to serial 1:2 dilutions of standard solutions containing each 
sugar at concentrations ranging from 0.5-500 mg/L. Sets containing blanks, unknown 
samples, and standard solutions were extracted, derivatized, and analyzed in a GC-MS 
session as described in the following protocol. 
Serum aliquots of 200 L each were thawed and pipetted into 2-ml plastic vials. 
Deproteinization was achieved by adding 600 L of methanol (EDM Chemicals, Inc. 
Gibbstown, New Jersey, USA) to each serum sample and mixing the sample for 20 
seconds using a vortex mixer. Samples were then centrifuged (Centrifuge 5417C, 
Eppendorf, Brinkmann Instruments Inc. Westbury, New York, USA) at 2,654 x g at 
room temperature for 7 min, and the supernatant was transferred to a 4-ml molded screw 
cap glass vial (VWR International, West Chester, Pennsylvania, USA). Samples were 
evaporated to dryness under a stream of nitrogen in a heating module (Reacti-Therm III, 
Pierce, Rockford, Illinois, USA) at 64°C for 30 min. Once the tubes were cooled, the 
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dried residue was derivatized in a two-step procedure. First, 50 L of Mox reagent (2% 
of Methoxyamine-HCl in pyridine) (Pierce) and 70 L of pure pyridine (Pierce) were 
added to each tube. Tubes were capped, vortexed for 20 seconds, and subsequently 
heated in a microwave oven at 100% energy level (800 W) for 2 min to promote the 
oximation reaction. 104 Then, samples were allowed to cool for 5 min and 100 L of 
N,O-bis[Trimethylsilyl]trifluoroacetamide (BSTFA) (Pierce) containing 1% TMCS were 
added to each tube. The tubes were capped, vortexed for 20 seconds and placed in a 
microwave oven at 100% energy level (800 W) for an additional 5 min to develop the 
silylation reaction according to the procedure described by Silva et al.104 Once the 
samples were cooled at room temperature, the derivatized extracts were evaporated to 
dryness under a nitrogen stream at 64°C for 8 min and then, the residues were dissolved 
in 250 L of hexane (EDM Chemicals, Inc). GC-MS analysis was performed with 1 µl 
of this solution. 
Gas chromatography analysis.  Derivatized samples were analyzed using gas 
chromatography (Gas chromatograph 6890N GC, Agilent Technologies, Inc. 
Headquarters, Santa Clara, California, USA) coupled with a mass spectrometer (Agilent 
Technologies, Inc.). Sugars were separated using a DB-1MS capillary column (30 m 
length, 250 m inner diameter, and 0.25 m film thickness) (Agilent Technologies, Inc.). 
The following GC column temperature program was used: the initial oven temperature 
was set at 100°C and held for 5 minutes. The temperature was then increased from 100 
to 325°C by a constant gradient of 15°C/min and held at 325°C for 5 min, resulting in a 
total run time of 23.33 min per sample. Helium was used as a carrier gas at a constant 
flow rate of 1.5 mL/min and at a velocity of 33 cm/sec. Sugar identification and 
characterization was performed under full-scan acquisition mode within the m/z 50 to 
m/z 1050 range. Sugar analysis and quantification were performed in selected ion 
monitoring (SIM) mode using m/z 204 for lactulose (L), m/z 117 for rhamnose (R), m/z 
147 for methylglucose (M), and m/z 217 for sucrose (S), xylose (X), and mannitol (m). 
Kinetic analysis. Calibration curves were established by plotting the ratios of the 
area under the curve of the peaks of the sugars of interest to that of the internal standard 
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for each of the different standard solutions using a polynomial curvilinear regression (y 
= ax2 + bx + c). Calibration curves ranged from 0.5 to 500 mg/L for each sugar with a 
mean r² = 0.997. The sugar peak area ratios of unknown serum samples were then 
extrapolated from the calibration curves. Statistical analysis was carried out using a 
commercial software program (GraphPad Prism 5). Sugar concentrations at all time 
points were analyzed for each sugar using a Friedman test with Dunn’s multiple 
comparison post test. Variation of the mean sugar concentrations of all dogs at 90, 120, 
and 180 minutes was analyzed using a Kruskal-Wallis test. Statistical significance was 
set at a p-value <0.05.  
 
RESULTS 
 The GC-MS analysis showed good peak resolution for all sugar probes. Fig. 3 
depicts representative total ion chromatograms (TIC) of the five target sugar probes in 
canine-serum samples at 180 min after oral administration. No overlapping peaks were 
observed among the five sugar standards (L, R, M, X, and S) and the internal standard 
mannitol (m).  
Permeation profiles. Table 7 shows the mean ± SD concentrations (mg/L) of 
lactulose, rhamnose, methylglucose, xylose, and sucrose in serum at individual time 
points after oral administration of the 5-sugar solution. The serum sugar showed 
significant concentrations of all five sugars at 30 min post dosing (the first sampling 
time). Monosaccharides (X, R, and M) reached the serum rapidly, while disaccharides (L 
and S) reached the serum more slowly. Quantifiable concentrations for all sugar markers 
were reached until the last sampling time point.  
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 Figures 10 to 14 show the mean ± SD concentration profiles for each sugar in 
serum, while the profiles for all five sugars are shown in Figure 15. Significant changes 
in the serum concentrations of all 5 sugars were detected after administration of the test 
dose (p<0.0001 for all 5 probes). Serum concentrations of  lactulose  and rhamnose  
were significantly different from the baseline at 90, 120, 180, 240 min, and at 60, 90, 
120, 180, 240, and 300 min post dosing respectively;  those of xylose, methylglucose, 
and sucrose were significantly different from the baseline at 30, 60, 90, 120, 180, and 
240 min post dosing (p<0.05 for all 5 probes).  
Maximum concentrations of lactulose (Fig. 10) and rhamnose (Fig. 11) were 
obtained at 180 min (mean ± SD: 8.2 ± 4.9 and 35.6 ± 4.0 mg/L, respectively) followed 
by a gradual decline, while xylose (Fig. 12), methylglucose (Fig. 13), and sucrose (Fig. 
6) reached their peak concentrations at 90 min post dosing (mean ± SD: 224.0 ± 72.6, 
214.8 ± 80.7, and 4.1 ± 1.7 mg/L, respectively) followed by a gradual decline. For all of 
the 5 sugar probes, no statistically significant differences were found between 
concentrations measured at 90, 120, and 180 min time points or between the coefficients 
of variation (%CV) of the mean concentrations for those 3 time points. 
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   Table 7: Mean ± SD concentrations (mg/L) and coefficient of variation (CV) of sugar probes in  
   serum. This table shows the five sugar concentrations in serum for each time period from dogs after  
   orogastric administration of a 5-sugar solution. 
Time Xylose Methylglucose Rhamnose Sucrose Lactulose 
min  mean     SD   CV%  mean     SD   CV% mean     SD   CV% mean     SD   CV% mean     SD   CV% 
0 
30 
60 
90 
120 
180 
240 
300 
360 
420 
480 
720 
1240 
     0.0      0.0     0.0  
121.4    51.1   42.1 
216.1    43.3   20.1 
224.0    77.6   34.7 
212.4    62.3   29.3 
153.2    50.2   32.8 
 85. 5    35.1   41.1 
  53.7     26.4   49.2 
28.4     12.1   42.5 
15.1       8.6   57.1 
  11.5      5.1   44.6    
    4.3      1.2   28.0    
    2.9     0.7    23.5 
    0.0      0.0     0.0   
140.4    74.1   52.8    
201.7    47.5   23.6    
214.8    86.2  40.1 
193.1    73.1  37.9     
144.8    44.2  30.6     
  91.9    39.9  43.5     
  61.8    18.1  45.5     
  44.4    16.1  36.3     
  26.0     6.6   25.5     
  22.0     8.5   38.8     
  12.4     5.7   45.7     
    3.8     1.4   37.4 
    0.0     0.0      0.0   
    9.1     2.6    28.7  
  19.5     4.4    22.7    
  29.9     8.8    29.5    
  33.9     8.6    25.2    
  35.6     4.3    12.0    
  26.5   10.1    38.3    
  18.0     6.8    38.0    
  11.9     4.0    33.5 
    8.5     2.5    29.3    
    6.6     2.5    37.5    
    3.7     1.2    34.0    
    2.1     0.2    10.7 
   0.0     0.0      0.0     
   3.2     1.3    40. 7    
   4.0     1.3    33.4     
   4.1     1.8    33.4     
   3.5     1.6    45.2     
   2.5     0.9    38.1     
   1.7     0.5    31.5     
   1.3     0.5    36.2     
   1.1     0.3    29.1     
   0.9     0.2    20.0     
   0.8     0.2    22.2     
   0.2     0.1    36.7           
   0.1     0.0    37.9        
   0.0     0.0      0.0   
   1.1     0.9    83.1     
   3.1     1.9    61.6     
   5.1     3.2    62.0     
   6.0     3.7    62.0     
   8.2     4.9    60.0     
   6.1     3.8    61.8     
   4.6     3.7    80.8     
   2.1     3.0  138.6     
   1.5     2.7  175.1     
   0.6     1.2  220.3     
0.0     0.0      0.0     
  0.0     0.0      0.0   
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Figure 10: Mean ± SD concentration-time profile of lactulose. This figure shows the  
changes of lactulose concentrations in serum after orogastric administration in healthy 
dogs (n= 8). Serum concentrations of lactulose were significantly different from baseline 
at 90, 120, 180, and 240 minutes post dosing (p<0.05), reaching the maximum peak 
concentration at 180 minutes post dosing (mean ± SD: 8.2 ± 4.9 mg/L).  
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Figure 11: Mean ± SD concentration-time profile of rhamnose. This figure shows the 
changes of rhamnose concentrations in serum after orogastric administration in healthy 
dogs (n= 8). Serum concentrations of rhamnose were significantly different from 
baseline at 60, 90, 120, 180, 240 and 300 minutes post dosing (p<0.05), reaching the 
maximum peak concentration at 180 min post dosing (mean ± SD: 35.6 ± 4.4 mg/L). 
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Figure 12: Mean ± SD concentration-time profile of xylose. This figure shows the 
changes of xylose concentrations in serum after orogastric administration in healthy dogs 
(n= 8). Serum concentrations of xylose were significantly different from baseline at 30, 
60, 90, 180, and 240 min post dosing (p<0.05), reaching the maximum peak 
concentration at 90 min post dosing (mean ± SD: 224.0 ± 72.6 mg/L). 
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Figure 13: Mean ± SD concentration-time profile of methylglucose. This figure 
shows the changes of methylglucose concentrations in serum after orogastric 
administration in healthy dogs (n= 8). Serum concentrations of methylglucose were 
significantly different from baseline at 30, 60, 90, 120, 180, and 240 min post dosing 
(p<0.05), reaching the maximum peak concentration at 90 min post dosing (mean ± SD: 
214.8 ± 80.7 mg/L). 
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Figure 14: Mean ± SD concentration-time profile of sucrose. This figure shows the 
changes of sucrose concentrations in serum after orogastric administration in healthy 
dogs (n= 8). Serum concentrations of sucrose were significantly different from baseline 
at 30, 60, 90, 120, 180, and 240 min post dosing (p<0.05), reaching the maximum peak 
concentration at 90 min post dosing (mean ± SD: 4.1 ± 1.7 mg/L). 
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Figure 15: Serum concentration-time curves of the five sugars after orogastric 
administration. Serum concentrations of xylose, rhamnose, and methylglucose are 
displayed on the y-axis on the left. Serum concentrations of lactulose and sucrose are 
displayed on the y-axis on the right. For all five sugars, no significant differences were 
found between concentrations measured at 90, 120, and 180 min time points or between 
the coefficients of variation (CV %) of the mean concentrations of these three points. 
 
 
 
 
 
 
 
 
 
 
  
55 
DISCUSSION  
The serum kinetics for 5 sugar probes commonly used for gastrointestinal 
permeability and intestinal absorptive capacity testing were assessed in this study. In 
general, sugar profiles in serum reflected a permeation and absorption pattern based on 
their physical and chemical characteristics. Taking into account the molecular 
dimensions, the monosaccharides xylose, methylglucose and rhamnose were absorbed 
faster and in higher amounts than the disaccharides. Therefore, the permeation pattern of 
lactulose and sucrose showed their selective size range to permeation by the 
gastrointestinal mucosa. 
Kinetic profiles of xylose and methylglucose in serum were consistent 
throughout the experiment. Both sugars showed identical appearance and clearance 
patterns in serum after the ingestion of the sugar solution. These findings compare well 
with results of kinetic studies of intestinal permeability in humans using xylose and 
methylglucose, which showed similar kinetic characteristics in plasma.52 In the present 
study, the maximum serum concentrations for these sugars were established at 90 min, 
and the X:M ratio with a mean ± SD of 1 ± 0.09 was consistently stable from 30 to 240 
min. 
The absorption of both monosaccharides occurs by mediated transport. Xylose is 
actively absorbed from the proximal small intestine (i.e., duodenum and jejunum), 
whereas methylglucose is absorbed throughout the length of the entire small intestine. 
Thus, a considerable reserve capacity exists for absorption of methylglucose, but not for 
xylose.127 Therefore, a decrease in the X:M ratio is a more reliable indicator of decreased 
absorptive capacity than xylose alone,133 because xylose is impaired to a greater extent 
than methylglucose in cases of mucosal damage, resulting in a subsequent decrease of 
the plasma X:M ratio.52 
Lactulose and rhamnose permeation showed a similar kinetic pattern through the 
study. Concentrations of these sugars showed a constant increase in serum until 180 min 
after oral administration. Serum concentrations from both sugars had a ratio of 0.27 ± 
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0.06 mean ± SD at this sampling time period in where their concentrations were 
significantly different from the baseline.  
The kinetic profiles of lactulose and rhamnose from the present study were 
similar to those reported in plasma from healthy dogs as previously measured by 
HPLC.97 These profiles suggest that both sugars diffuse the intestinal mucosa by two 
distinct pathways with lactulose passing the intestinal mucosa through relatively large 
pores present at low abundance that is associated with the paracellular tight junction. 
Rhamnose crosses mainly through the small aqueous pores present at high abundance at 
the epithelial cell membrane. Intestinal disease leading to injury of the small intestinal 
mucosa leads to an abnormal mucosal permeability that is characterized by an increased 
L:R ratio.52  
Many diseases affecting the small intestinal mucosa are characterized by villous 
atrophy which may lead to a reduced mucosal surface area for the diffusion of rhamnose, 
allowing an increased diffusion of lactulose in the crypt region due to a wide availability 
of large pores accompanying the mucosal damage. Serum L:R ratios were used to 
distinguish between subjects with villous atrophy and those with normal biopsies at  60, 
90, and 120 min post-ingestion in humans.72  
In regard to sucrose, this sugar was observed in small concentrations in serum.  
Under normal circumstances, ingested sucrose is rapidly hydrolyzed in the proximal 
small intestine by the enzyme sucrase into sucrose and. The normal gastric mucosa only 
allows a small quantity of sucrose to be absorbed before it is exposed to sucrase activity 
in the small intestine. During studies in animal models to identify site specific 
gastrointestinal permeability, sucrose could never be found beyond the stomach after rats 
received a gavage containing mixed sugar solutions containing sucrose.37 An increase in 
gastric mucosal permeability to sucrose in NSAID gastropathy has been shown in 
humans.134  
Reports of gut permeability to inert sugars in animal models (rabbits and mice) 
have  shown an appropriate measure of lactulose to be at 180 min post dosing, whereas 
rhamnose showed its best expression at 120 min post dosing.71 These values fall into the 
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range obtained from dogs in this study. The sucrose kinetic pattern observed in the 
present study showed significant statistical difference from the baseline at 30, 60, 90, 
120, 180, and 240 min post dosing. This kinetic pattern closely resembles that reported 
for serum sucrose in human beings. Those studies showed that, in humans, 
gastroduodenal injury can be detected using serum at any determined point between 30 
and 300 min.135  
In conclusion, after orogastric administration of a sugar solution containing 
lactulose, rhamnose, xylose, methylglucose, and sucrose serum concentrations could be 
detected in all dogs after 30 minutes of administration. While the peaks of serum 
concentrations differed for the 5 sugar probes, there was no significant difference in 
serum concentrations between the 90 to 180 minutes timed blood sampling periods. 
Thus, it may be feasible to detect gastrointestinal injury (reflected by alterations in 
permeability and absorptive capacity) by collecting a baseline sample and a 90-180 min 
post administration sample. 
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CHAPTER IV 
 
DISCUSSION 
 
The assessment of gastrointestinal permeability and intestinal absorptive capacity 
has been used as a clinical research tool in human and veterinary medicine, and has also 
been used to evaluate the gastrointestinal barrier function in patients with a variety of 
gastrointestinal and systemic diseases.136 The barrier function of the gastrointestinal tract 
can be assessed by evaluating intestinal permeability through the assessment of marker 
molecules that diffuse passively through the mucosa.43 In contrast, intestinal absorptive 
capacity can be assessed by evaluating molecules that are absorbed by carrier-mediated 
transport.43  
Measurement of marker molecules in urine after oral administration has been 
established as a tool for noninvasive investigation of small intestinal permeability and 
mucosal absorptive capacity.72 However, one major source of error for this type of 
investigation lies in the ability to collect all of the urine samples over a period of several 
hours.137 In addition, the most common methods used for the measurement of these 
marker are characterized by a lack of sensitivity to the marker molecules in urine.138 In 
this study, the development and validation of a GC-MS method for the simultaneous 
measurement of lactulose, rhamnose, 3-O-methyl-D-glucose, xylose, and sucrose is 
described. Furthermore, serum profiles for these sugars in dogs are evaluated to provide 
the basic elements for an alternative for urine collection. 
All sugars used in the GC-MS method described here have been previously used 
safely in humans14 and companion animals.48,51,58,97,139 Thus, these sugars have been a 
good choice for use as probes to assess intestinal permeability and mucosal absorptive 
capacity.137,140 For example, lactulose and rhamnose are the most commonly used sugar 
probes.37 The disaccharide lactulose crosses the intestinal epithelium by passive 
diffusion through paracellular tight junctions, while the monosaccharide rhamnose 
crosses the intestinal epithelium by transcellular passive diffusion through aqueous 
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pores.141 The lactulose to rhamnose urinary recovery ratio is a well-established method 
for assessing intestinal permeability.37 In addition, xylose and methylglucose are 
monosaccharides that are absorbed by intestinal epithelial cells via passive and active 
carrier-mediated transport, respectively.141 Finally ,sucrose has been described as a 
marker for assessment of gastric permeability.140  
Traditionally, gastrointestinal permeability has been estimated by the 
measurement of sugars in urine after oral administration of a solution containing a 
mixture of sugar probes. Subsequently, measurements are then performed on urine 
collected during a five to six hour test period. However, the collection of urine samples 
during this test period can be difficult, particularly in pediatric and veterinary 
patients.97,141, In addition to mucosal factors affecting permeability of the intestinal 
epithelium, a variety of pre-mucosal and post-mucosal factors might influence the 
urinary excretion of an orally administrated probe.142 Also, the urinary recovery of some 
permeability markers (e.g., mannitol) can produce confounding factors due to alterations 
in renal function, more specifically, a low glomerular filtration rate.142 More recently, 
several studies in dogs and humans have reported about the measurement of sugar 
permeability markers in serum rather than urine.97,143 However, these initial studies have 
utilized HPLC for separation of the sugar probes and PAD for quantification, which has 
proved to be difficult for these closely related mono- and disaccharides. Consequently, 
interest in GC-MS analysis of these mono- and disaccharides has arisen.  
In the first part of this study (Chapter II), an accurate, precise, and practical GC-
MS method for the simultaneous analysis of lactulose, rhamnose, methylgluccose, 
xylose, and sucrose in spiked serum was developed and analytically validated. 
Subsequently, the GC-MS method was used for the measurement of these sugars in 
serum from healthy dogs (Chapter III) in order to establish the kinetic profiles of GI 
permeability-absorption markers once administered by orogastric intubation.  
The refinement of the validated method was achieved by focusing on the critical 
steps related to metabolite analysis by GC-MS: extraction, derivatization, and 
separation.144 A proper estimation of the concentration of any metabolite in a biological 
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sample is difficult because the composition of these samples contains a wide variety of 
constituents and chemicals with varying natures.120 Serum is a complex matrix for 
chromatography, as it contains many substances. These substances all have the potential 
to affect the chromatographic measurements of the marker molecules of interest. 
Therefore, one goal of this study was to develop a method with as high extraction 
efficiency and reproducibility as possible for the GC-MS analysis without affecting the 
target probes themselves. Therefore, several methods, such as the addition of organic 
solvents145,75 or salts,146 and acidification using strong acids were used to precipitate 
proteins from biological fluids for the extraction of metabolites to be measured by GC-
MS.147  
Some overlapping peaks between endogenous glucose and our sugar markers of 
interest have previously been reported for urine samples. Pretreatment of urine by 
enzymatic degradation of glucose was needed to overcome this problem.110 Similarly, in 
a previous report using HPLC-PAD for measurement of serum sugar probes, xylose 
eluted in close proximity to the endogenous serum sugar glucose, making measurement 
of serum xylose concentration difficult. Therefore, enzymatic pretreatment with glucose 
catalase and plasma protein precipitation were both used in that study as part of the 
extraction procedure to eliminate the interference of endogenous glucose. However, that 
procedure was considered time consuming and, therefore, impractical.97 In an HPLC-
PAD assay for the measurement of five sugar probes in serum previously developed and 
validated in our laboratory, enzymatic pretreatment and deproteinization were also 
considered necessary to obtain a more pure sample (unpublished data). Despite such 
pretreatment, the method failed to produce reproducible results and was thus abandoned.  
For the sugar analysis reported here, multiple pretreatments of the serum samples 
were not necessary. Consequently, the extraction method is relatively simple compared 
to the previously described methods. Thus, serum proteins were precipitated by a 
combination of centrifugation and by addition of the organic solvent methanol as 
reported previously for a microwave-assisted derivatization method.145 Although the use 
of methanol as a solvent for sugar extraction has been debated due to the potential 
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problems it may introduce, such as transmethylation of sugar esters, methanol is a more 
efficient extraction solvent than either ethanol or acetonitryl.120 For example, sugar 
extractions using 80% methanol have been shown to have a recovery rate of 97% as 
determined by CG-MS.144 In addition, in a subsequent step, methanol evaporation 
allowed the aqueous phase of the reaction mixture to be removed. This step is considered 
crucial because moisture in the extracted samples can produce derivatization artifacts or 
poorly derivatized compounds due to hydrophobic characteristics of the derivatization 
reagents.148  
Therefore, the effectiveness of the extraction procedure used in this study was 
assessed by the measurement of the studied markers in serum samples that were spiked 
with increasing concentrations of the 5 sugar markers. This allowed for the 
determination of dilutional parallelism, spiking recovery, and coefficients of variation 
for intra- and inter-assay variability. Furthermore, the assays for all five sugars 
performed to acceptable standards, suggesting that the extraction and measurement 
procedures were effective. 
The use of GC-MS rather than HPLC allows for better resolution of sugars119 and 
is, therefore, considered superior for the measurement of serum concentrations of sugar 
markers. However, one of the major concerns with the use of GC-MS is that 
chromatograms contain multiple peaks that are generated by derivatized sugars.149 
Therefore, a suitable derivatization procedure was required prior to the GC-MS sugar 
analysis. As a result, many derivatization procedures have been described in the 
literature for carbohydrate analysis.80,111,112 One such derivatization procedure is 
characterized by the substitution of polar groups (e.g., hydroxyl groups).80  
In this study, several combinations of established derivatization protocols were 
evaluated in both individual and mixed serum samples. The purpose of this 
derivatization step is to increase the volatility and thermostability of the extracted 
samples.111 Volatility is desirable, as it allows the marker to enter the gas phase and 
consequently the GC column.112 The increased thermostability decreases the likelihood 
that a marker molecule will fragment under the high temperature conditions present in 
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the GC-MS. Such fragmentation could lead to the formation of multiple peaks in the 
chromatogram.150 Other derivatization methods have been described to be used for 
sugars. Alditol acetate derivatization has been considered very useful for the 
measurement of reduced end sugars.73 However, the alditol acetate derivatization 
reaction was not considered appropriate for this study, as this reaction can be associated 
with the generation of other sugar derivatives from glucose and fructose, such as 
mannitol.114 Glucose and fructose are endogenous sugars present in serum samples and 
thus could be available in unpredictable quantities in each serum sample. Therefore, the 
alditol acetate derivatization reaction could have led to chromatograms with overlapping 
peaks due to the generation of carbohydrates that are structurally closely related to the 
carbohydrates of interest.151 Additionally, the generation of mannitol would have altered 
the concentration of the internal standard, making quantification of the sugar markers 
impossible.  
Another derivatization procedure, per-O-methylation, has been developed for the 
measurement of carbohydrates in aqueous solution.149 Per-O-methylation requires the 
presence of water for the interaction of carbohydrates with solvents during the 
derivatization procedure. Therefore, this reaction avoids the oxidation of carbohydrates 
generated by the interaction between dimethyl sulfoxide and methyl iodide, the major 
derivative components of this method.149  
Because of the limitations of the two previously discussed procedures, the 
oxime-trimethylsilyl derivatization procedure was selected for the chemical conversion 
of the sugar probes used of this study. Polar compounds containing functional groups, 
such as –OH were derivatized by adding a trimethylsilyl (TMS) group, called TMS-
ethers. Because TMS groups lead to more volatile and thermostable compounds, TMS-
ethers of mono- and disaccharides are easily prepared and separated 
chromatographically.80,81 Sugar chromatographic characteristics were evaluated before 
sugar analysis. TMS-derivatization of monosaccharides usually results in the formation 
of multiple peaks.152 For the protocol used here, the peak issue was solved by converting 
the aldehyde and keto groups into oximes before forming TMS ethers to reduce the 
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number of tautomeric forms as suggested previously by Curtis et al.153 This structural 
change has been explained as a limited rotation along the C=N bond, resulting only in 
the formation of syn and anti forms.154 
The oxime-trimethylsilyl derivatization procedure was evaluated during several 
assay runs, and a two-step derivatization protocol was chosen. The first reaction, 
oximation, was performed for two minutes and then the second one, silylation, was 
performed for five minutes, immediately before the samples were introduced into the 
GC-MS instrument. Both reactions were carried out in a microwave oven. Microwave-
assisted derivatization is being used with increasing frequency.155,104,156 Also, microwave 
use allowed for a reduced derivatization time in this study, compared to a recently 
reported method for which sugar oximation step had to be carried out for 12 or more 
hours.120 Also, in comparison with conventional heating derivatization methods, the 
chromatograms generated by the metabolites resulting from microwave-assisted 
derivatization showed a well-defined resolution.  
For sugar identification, a full scan MS method (m/z 50 to 1050) was used to 
select the appropriated ions. In order to increase the sensitivity of the analysis, a SIM 
mode was selected, which provided a much higher response than the full scan mode for 
the target sugars. For a better sensitivity and sugar identification, the most abundant 
fragments of each sugar were selected. This resulted in being able to easily identify and 
quantify the sugars by selecting single ion chromatograms from their selected ions as has 
been suggested in previous studies.157  
Ion chromatograms were generated for each sugar at which point the 
chromatography peaks of the various sugars and their retention times were identified. In 
fact, the peaks and specific retention times generated for each sugar (Table 1) represent a 
potentially useful method for their direct identification. Also, the mass spectra for each 
sugar were recorded and compared with those previously reported.76 Using the protocol 
developed here, the chromatograms did not display overlapping peaks among the sugars 
analyzed. Furthermore, no overlap was observed between the peaks created by the sugar 
markers of interest and endogenous sugars. 
  
64 
The oxime-TMS derivatization method is able to reduce the number of 
trimethylsilyl isomers.158 Some sugars such as rhamnose (Figure 6) and xylose (Figure 
7) generated two chromatogram peaks, which represent the syn and anti configuration 
forms, where one form greatly predominates over the other.159 It has been reported that 
by measuring the larger peak the presence of the minor peak has no effect on assay 
reproducibility.160 In contrast, methylglucose and lactulose showed three peaks in their 
chromatograms. However, all 3 peaks could be well separated. Sucrose, which is 
classified as a non-reducing end sugar, usually generates a single peak with most 
derivatization procedures.73,149 In Figures 2 and 3 it can be observed that the 
chromatographic peaks eluted according to the number of carbon atoms. The smaller the 
number of carbon atoms of the monosaccharide, the shorter the retention time.151 
The stability of TMS of mixed standards in serum was examined. During the 
examination of the standards, derivatized compounds were analyzed immediately after 
derivatization and were stored at room temperature or at 4º Celsius and analyzed again 
after 3 days. When comparing the chromatograms from samples analyzed immediately 
after derivatization and the same samples that had been derivatized and stored for several 
days, the same chromatogram resolution and peak intensity was observed. This 
observation demonstrates the stability of the derivatized marker molecules. Silyl 
derivatized products generated with BSTFA have demonstrated good stability at room 
temperature for 3 days after derivatization.101 Stability of derivatized sugar samples is 
crucial when the interval between analysis of the first and the last samples of a GC-MS 
assay run is more than 12 hours. 
The relative retention times of the sugars monitored and their selected ions 
allowed unequivocal identification and differentiation of all sugar probes used for this 
study. This can be observed in the representative ion chromatograms (Figure 2) of a 
serum sample spiked with all sugars. The ion chromatogram indicates adequate 
separation of the sugar probes. This is in contrast to previous assays methods, which 
resulted in difficulties for disaccharides identification and separation.138 The use of 
relative retention time has been advocated to enhance reproducibility.161 Because some 
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sugar probes used for this experiment are chemically closer to each other, the 
combination of the mass spectrometry and retention times have great significance for the 
differentiation of substances with similar mass spectra.161 Thus, for compound 
identification, GC retention times from unknown samples were continuously correlated 
with those of the standards. The mass spectra of our target sugars correlated with the 
most common ions reported for pentoses and hexoses under oxime-TMS derivative 
forms.118 Therefore, these mass spectra were adjusted to a single intensity for 
convenience of sugar identification and quantification using a selected ion monitoring 
method (SIM).98 The characteristics of the sugar chromatograms were consistent during 
all GC-MS runs. Also, the detection limits for the sugar probes analyzed in this study are 
low when compared with values reported for analysis of the same sugars by capillary 
electrophoresis107 and HPLC-based methods.72,106  
This study represents the first analytical method for simultaneous separation and 
identification of five sugar probes in canine serum by GC-MS. The method was carried 
out following trimethylsilyl derivatization using the target and referenced ions (Table 1) 
to help reduce the influence of extraneous peaks and to ensure that any peak appearing in 
the SIM mode belonged to the monosaccharides and disaccharides used in this 
experiment. Table 7 shows that calibration curves for each sugar probe were linear 
within the measured range between 0.5 to 500 mg/L with mean correlation coefficients 
(r²) of 0.997. 
In this study, the absolute recoveries for the sugars showed a mean ± SD of 106.2 
± 13.0%. Slightly higher recoveries were observed for L, R, X, and M (Table 3) in serum 
samples spiked at the lowest concentrations. It is likely that the wide range of the 
standard curves used for this study were responsible for this overestimation of sugar 
concentrations. A similar overestimation was observed in successive studies when sugar 
concentrations were estimated using the same range (0.5 to 500 mg/L) employed for the 
present experiment. This situation could be corrected by calculating sugar concentrations 
using a narrower range for the standard curves used.  
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Sucrose showed the lowest recovery percentage. Low accuracy for detection and 
quantification of sucrose at small concentrations compared with higher concentrations 
has been reported using gas chromatography.119 Consequently, recovery can be 
influenced by loss of the analyte during extraction and oximation derivatization. Also, 
sucrose degradation may occur as a result of the extraction method and oxime 
derivatization.120  
The lower detection limit was 0.03 mg/L for L, R, M, and X, and 0.12 mg/L for 
S. The accuracy and precision for the five sugars was deemed sufficient to allow further 
measurement of sugar probes for the assessment of gastrointestinal permeability and 
intestinal absorptive capacity in dogs. Since this is the first validated method of analysis 
for five sugars in serum samples using GC-MS, there is no other method available for 
comparison of accuracy and precision. The %CVs for the intra-assay variability were 
6.8% to 12.8% and for the inter-assay variability 6.4% to 15.9% for all five sugars. The 
coefficients of variation obtained were lower than 16%, indicating a good performance 
of this method. These values, which are representative of precision and reproducibility, 
respectively, are in agreement with the general accepted criterion for gas 
chromatography-mass spectrometry established for the detection of substances in 
biological matrices.162 
For the second part of this study, the described GC-MS method was used to 
establish serum kinetic profiles for L, R, M, X, and S in dogs after a solution containing 
these sugars was administered by orogastric intubation.  
Currently, available methods for assessment of intestinal permeability involve 
evaluation of the mucosal transport of saccharides, radioactive markers (i.e., 51Cr-
EDTA), and polyethylene glycol or by a combination of these markers. Radioactive 
markers are easily measured and are inexpensive to analyze.163 Furthermore, they can 
also be detected in blood samples.44 However, using radioactive markers require 
exposure of both patients and personnel to ionizing radiation.164 In addition, diagnostic 
specificity may be lacking since increased absorption of some of these markers may 
occur in a variety of intestinal diseases, including gluten enterophaty,165 iatrogenic 
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enteropathy due to nonsteroidal drug administration,166 and Crohn’s disease.167 In 
contrast, sugar probes cross the intestinal mucosa via specific pathways, often limited to 
a specific segment of bowel.163  
Polyethylene glycol exists in a variety of sizes and can be used as a marker for 
intestinal permeability. Smaller polymers permeate the mucosa faster than rhamnose, 
while the permeation rate for the larger polymers is higher than those for 51Cr-EDTA or 
lactulose.42,168 In addition, low urine excretion levels of PEG-400 in relation to 
saccharides and 51Cr-EDTA  suggested that the probe may not be sufficiently sensitive to 
assess intestinal permeability in more subtle disorders of barrier function.43 Therefore, 
differences in permeation rates and their tendency to be retained by tissues make PEG 
less ideal for the evaluation of intestinal permeability.42 All these markers are orally 
administered and are mostly measured in urine. However, the above methods are 
cumbersome and too laborious for use as a routine test because they require the 
collection of urine over long periods and/or the use radioisotopes. Therefore, we 
developed a new method to assess intestinal permeability by sampling blood instead of 
urine.  
GI permeability tests using serum have not been published extensively. Most of 
these use only one sugar probe such as sucrose,169,70,138,94 xylose,170,171,172 3-O-
methylglucose,173 and lactulose,174 or two sugar markers such as lactulose and 
rhamnose,71 or lactulose and mannitol72,93 to evaluate GI permeability and/or intestinal 
absorptive capacity. In addition, some of these studies in serum have been characterized 
by one or two randomly timed blood samples,138,170 or blood samples taken a long time 
after the test solution had been administered.175 Therefore, accurate inferences related to 
gastrointestinal permeability have been absent due to a lack of consecutive 
measurements of sugar concentrations in serum. So far, the most advanced contribution 
for the assessment of GI permeability and mucosal function testing using serum have 
been tests in which sugar probes are measured simultaneously in serum and urine 
collected between two to six hours after sugar markers were orally administered.97,175,176 
In a comparative study performed for the assessment of intestinal permeability in human 
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patients with inflammatory bowel disease, in which lactulose was measured in serum 
and urine, urinary lactulose recoveries changed in parallel with the blood values.174  
These considerations prompted us to analyze the kinetics of the sugar probes in 
healthy dogs in serum instead of urine. In this experiment, we measured the 
concentrations of L, R, X, M, and, S in serum using the validated GC-MS method. After 
their administration by orogastric intubation, a rapid appearance of the monosaccharides 
xylose, methylglucose and rhamnose in serum was observed. The serum concentrations 
of rhamnose, methylglucose, and xylose were significantly increased compared to 
baseline concentrations. Overall, serum concentrations for lactulose and sucrose were a 
lot lower than those for the other sugars. Intestinal mucosal permeation of disaccharides 
is influenced to a certain extent by the molecular size, which dictates the pathways used 
for these saccharides.  
In general, serum concentrations of sugar probes showed a well defined profile 
over the entire sampling period until they reached the limit of resolution. Kinetic profiles 
for the monosaccharides xylose and methylglucose in serum were consistent throughout 
the experiment. More over, they reached the maximum peak concentration at 90 min 
post dosing followed by a gradual decline. Both sugars showed identical appearance and 
clearance patterns in serum after the ingestion of the sugar solution. These findings 
compare well with results of kinetic studies of intestinal permeability in humans using 
xylose and methylglucose, which showed similar kinetic characteristics in plasma.52 
Both sugars are absorbed rapidly in the upper jejunum.177 Also, both sugars reach their 
maximum concentration at 90 min after ingestion. It is at this time point when absorption 
and excretion of a substance are in balance.178  
In a study, which evaluated xylose absorption in human patients, absorption of 
this sugar averaged 81% of the oral dose in normal subjects, compared to less than 60% 
of the oral dose in patient with various absorptive pathologies. In both cases the 
maximum serum concentrations of xylose were found at 90 minutes after oral 
administration.179 Also, in studies of xylose absorption in polygastric species, serum 
kinetic profiles of xylose showed a maximum peak concentration at 90 min.180 Studies in 
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different animal species that evaluated the rate of xylose absorption suggested that 
absorption is influenced primarily by the gastric empting rate.181-183 Also, small intestinal 
motility, the surface area available for absorption, and the microbiota of the small 
intestine influence the kinetics of xylose absorption.180,182,184 The oral bioavailability of 
xylose has been reported to be 90% in rats and 81% in humans. In horses only 30% of 
xylose is absorbed, and is further metabolized in the large intestine.185  
The inclusion of an actively transported but non-metabolizable marker in an 
intestinal permeability tests, such as methylglucose, should reflect the overall absorptive 
capacity of the small bowel (i.e., surface area),186 but it would also reflect alterations in 
gastric emptying, small intestinal motility patterns, the mucosal barrier with the unstirred 
water layer of the small intestine, and finally the transport capacity of the enterocytes.187 
Several studies have shown that the small intestine has a large reserve capacity for the 
active mediated absorption of methylglucose in contrast to xylose, anticipating a relative 
insensitivity of methylglucose for intestinal damage when compared to xylose.  
  On the other hand, serum concentrations of lactulose and rhamnose were 
significantly different between baseline and 90 to 240 and 60 to 300 min post dosing, 
respectively. Such values are in close agreement with those found in a control group of 
dogs in a study reported by Sørensen et al..97 Mean maximum concentrations of lactulose 
(mean ± SD: 8.2 ± 4.9 mg/L) and rhamnose (mean ± SD 35.6 ± 4.0 mg/L) were obtained 
at 180 minutes, followed by a gradual decline. The sugar profiles of both sugars are a 
reflection of their permeation characteristics. According to Maxton et al., two distinct 
pathways are hypothesized for unmediated mucosal permeation: one consisting of small 
pores in the cell membrane of enterocytes through which rhamnose passes and the other 
of large channels related to the tight junctions and/or extrusion zones.41 
Monosaccharides, such as rhamnose or mannitol reflect the degree of 
transcellular permeation of small molecules (0.65 nm). Disaccharides, such as lactulose 
or cellobiose, reflect paracellular permeation of larger molecules (0.93 nm).188 Thus, the 
kinetic profiles of serum concentrations displayed by lactulose and rhamnose follow 
these permeation principles, with rhamnose being the smaller molecule and lactulose 
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being the larger molecule, which is only able to permeate through the relatively 
infrequent paracellular pores. 
 Several studies have assessed the passive permeability characteristics of the 
small intestine using water-soluble probes that differ in molecular size, such as 
carbohydrates168,189 or polyethylene glycol (PEG) of varying molecular weights.40,190 In 
these studies, absorption declined as the increasing molecular weight of probes more 
rapidly than the free aqueous diffusion coefficients of the probes, consistent with 
movement. A phenomenon called solvent drag generated by water movement has been 
used to explain differences in the permeation of compounds with similar characteristics 
but a different molecular size. Thus, the solvent drag affects, presumably, the flux 
through pores that selectively allow the passage of smaller molecules and are restrictive 
to larger-sized molecules.191 Pioneers in the intestinal permeability field stated that the 
osmotic pressure gradient between plasma and luminal content is not consistent from the 
upper to the lower small intestine.192Also, the ability of a given concentration gradient to 
promote the movement of water varies with the molecular size of substances used. As a 
result, the ability of a non-lipid soluble solute to generate effective osmotic pressure is 
inversely related to its ability to penetrate the membrane, which in turn is dependent 
upon the molecular size of the substance in question. Such an observation was markedly 
expressed from the jejunum to the ileum because the pore radius in the jejunum is twice 
the size of the effective pore radius in the ileum.192 Not surprisingly, serum profiles of 
lactulose and rhamnose (Figure 15) give an indication of the size selectivity of the 
different pathways.  
Under normal circumstances, ingested sucrose passes into the small intestine 
where it is rapidly degraded by brush border disaccharidases.136 Sucrose, being a 
disaccharide, is believed to be absorbed via the paracellular route and reflects the 
permeability of the intercellular tight junctions.43 In the present study the sucrose probe 
showed a serum profile with a small increase in the serum concentration (mean ± SD: 
4.1 ± 1.7 mg/L). Low serum sucrose concentrations under physiologic conditions are due 
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to a much smaller surface area and shorter contact time of the sugar probe in the 
stomach.83 
In theory, sucrose should not permeate the gastric mucosa in healthy individuals. 
In a screening test to detect sucrosemia in celiac disease developed by Cox et al., sucrose 
was not found in normal control subjects in serum samples taken at 45 min and 2 hours 
after ingestion of 50 g of sucrose. In contrast, other data showed sucrose in urine 
collected from normal subjects after ingestion of 100 g of sucrose.138 The results of this 
study assumed differences in the administered dose, as well as differences in the 
sensitivity of HPLC analysis of urine collected over a period of 6 hours in comparison to 
a single serum sample. Furthermore, in this study, the serum kinetic profile for sucrose 
compared well with the sucrose profile obtained in normal human volunteers.70  
In summary, we collected blood specimens from 8 dogs at 13 different sampling 
times during 24 hours and examined the changes in serum lactulose, rhamnose, 
methylglucose, xylose, and sucrose concentrations in order to determine a time point 
appropriate for collection of a serum sample for gastrointestinal permeability and 
mucosal function testing. There was no significant difference of the sugar concentration 
of any of the 5 sugars between 90 and 180 minutes after administration. Thus, it may be 
possible to use a single serum sample collected at any point between 90 and 180 min 
after the administration of the sugar probes.  
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CHAPTER V 
 
CONCLUSIONS 
 
In this study, a method for the simultaneous quantitation of lactulose, rhamnose, 
methylglucose, xylose, and sucrose in canine serum was developed and analytically 
validated. The method included deproteinization of serum samples and a two-step 
derivatization process combined with gas chromatography mass spectroscopy analysis.  
The results obtained from the present study extend the possibilities for 
gastrointestinal permeability and mucosal function testing. The described GC-MS 
method was used to determine serum kinetic profiles for lactulose, rhamnose, 
methylglucose, xylose, and sucrose in dogs after administration of a solution containing 
these sugars by orogastric intubation. Measureable serum concentrations of the 
monosaccharides xylose, methylglucose, and rhamnose appeared in the serum shortly 
after administration. In contrast to the concentrations of the monosaccharides, the 
disaccharides lactulose and sucrose only reached much lower concentrations in the 
serum, suggesting a low level of gastrointestinal permeation.  
For all of the 5 sugar probes, no statistically significant differences were found 
between concentrations measured at 90, 120, and 180 min after administration. Thus, it 
may be feasible to detect gastrointestinal injury (reflected by alterations in permeability 
and absorptive capacity) using serum obtained by only two blood samples: one sample 
taken at baseline and a second sample taken between 90 to 180 min post-dosing of sugar 
probes.  
Results generated from this study provide a new method for the evaluation of the 
integrity of the gastrointestinal mucosa, which can not be achieved by conventional 
diagnostic techniques. Furthermore, information about gastrointestinal permeability and 
mucosal absorptive capacity might complement the information provided by 
conventional techniques used for the characterization and distribution of gross and 
histopathologic lesions. Also, the minimally-invasive nature of permeability and 
  
73 
absorption tests would allow these tests to be used routinely for diagnostic screening of 
clinical patients and also as a research tool, and could possibly replace the need for more 
invasive endoscopy and biopsy procedures. Consequently, the use of such minimally-
invasive methods provides the option for clinicians and researchers in gastroenterology 
to test intestinal permeability and absorptive capacity, which allows for assessment of an 
important function of the gastrointestinal mucosa.  
As described earlier, most of the assays described in the literature for 
permeability testing in serum used methods other than GC-MS. The major improvement 
of our method compared to those previously described is the simultaneous determination 
of five sugars in serum. Furthermore, the use of GC-MS has led to a more sensitive 
method, compared to the published protocols. The use of this sensitive method for the 
measurement of serum concentrations of sugar markers to predict GI permeability and 
absorptive capacity in a clinical setting would be the next step for evaluation of the 
clinical usefulness.  
For example, these measurements could provide information complementary to 
the results of other diagnostic tests, such as histopathology or laparoscopy. It would 
seem reasonable to assume that having the ability to detect low concentrations of sugars 
in serum would substantially enhance the power of GI permeability and absorption tests. 
Therefore, it may be plausible that the current GC-MS assay, capable of detecting low 
concentrations of sugars of 0.03 mg/dl, would be clinically more useful than previously 
described. Ultimately, the cost, applicability, practicality, and availability of the GC-MS 
assay will need to be compared with the methods previously described to determine 
which assay might be preferable for wide-scale application.  
In conclusion, we described the development and analytical validation of a GC-
MS method for the simultaneous determination of five sugar probes in canine serum. 
Also, the kinetic study showed no statistically significant differences for all of the 5 
sugar probes when measured at 90, 120, and 180 min after administration, suggesting 
that a simple sample post-dosing may be sufficient to evaluate permeability and 
absorptive capacity for all five sugar probes. 
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